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ABBREVIATIONS AND DEFINITIONS 
This PhD thesis should be of interest to academia but also to the industry, e.g., 
telehealthcare developers, decision makers in telehealth implementation, health care 
providers, policy makers, and others who have an interest in this matter. The 
Vancouver reference system will be used in this thesis. 
ABBREVIATIONS 
 
CAT  COPD Assessment Score 
COPD  Chronic Obstructive Pulmonary Disease 
FEV1  Forced Expiratory Volume 
FEV1/FVC  Tiffeneau-Pinelli Index 
FVC  Forced Vital Capacity 
GOLD The Global Initiative for Chronic Obstructive Lung 
Disease  
GP  General Practitioner  
GSM  Global System for Mobile Communications 
HRQoL  Health-related Quality of Life 
ICER  Incremental Cost-effectiveness Ratio 
ISO  International Organization for Standardization  
MCS  Mental Component Score 
MRC  Medical Research Council Dyspnea Scale 
PCS  Physical Component Score 
QALY  Quality-adjusted Life Years 
QoL  Quality of Life 
RCT  Randomized Controlled Trial 
SF-36  The Short-Form (36) Health Survey  
SF-36v2  The Short-Form (36) Health Survey, Version 2 
WHO  World Health Organization 
WSD  Whole System Demonstrator Project 
 
DEFINITIONS 
 
District nurses The term refers to the nurses working in the primary 
care. In the TeleCare North trial, these nurses 
monitored the patients’ data and provided the 
patients with telephone advice  
 
Effectiveness The term refers to whether a given intervention 
obtains the intended outcomes and encompasses 
issues such as: “Does the intervention work?” and 
“Who will benefit from its use?” (1) 
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Health Literacy Health literacy can be defined as: “the cognitive 
and social skills which determine the motivation 
and ability of individuals to gain access to, 
understand, and use information in ways which 
promote and maintain good health” (2) 
Health-related Quality of Life The term encompasses the core components: 
physical, functional, social, and emotional well-
being of an individual (3)  
 
Patient The term relates throughout this thesis to people 
enrolled in the TeleCare North trial. These people 
are all residing in the North Denmark Region and 
diagnosed with COPD  
 
Patient Empowerment Patient empowerment is in total defined as: “the 
acquisition of motivation (self-awareness and 
attitude through engagement) and ability (skills and 
knowledge through enablement) that patients might 
use to be involved or participate in decision-
making, thus creating an opportunity for higher 
levels of power in their relationship with 
professionals” (4) 
 
Telehealthcare Telehealthcare is defined as: “the provision of 
personalized health care from a distance” (5) 
 
Telekit The term refers to the telehealthcare system used in 
the TeleCare North trial. The Telekit system guides 
the patients in managing their disease during 
exacerbations  
 
Usability The term is by ISO defined as: “Extent to which a 
system, product or service can be used by specified 
users to achieve specified goals with effectiveness, 
efficiency and satisfaction in a specified context of 
use” (6)  
 
User experiences The conceptualization of user experiences is as 
follows: “a person's perceptions and responses that 
result from the use and/or anticipated use of a 
product, system or service” (7)
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ENGLISH SUMMARY 
[Introduction] The healthcare system is currently facing challenges in the treatment 
of chronic obstructive pulmonary disease (COPD), which has created the need for 
alternative ways to treat these patients. Telehealthcare could be this alternative. A 
range of studies have been conducted to evaluate the effectiveness of telehealthcare, 
but they generally conclude that there is a need for more large-scale studies to obtain 
sufficient evidence.      
[Objectives] Taking this into consideration, the main aim of this PhD study was to 
evaluate a telehealthcare intervention for patients suffering from COPD. This thesis 
had a more specific focus on the following: I) developing a study protocol for the 
Danish, large-scale trial, TeleCare North; II) evaluating the trial’s telehealthcare 
system (coined Telekit) in terms of its usability and patient experiences; and III) 
evaluating the trial’s primary outcome, health-related quality of life (HRQoL). 
These focus areas have been addressed in seven papers. 
[Paper I] A study protocol was developed in which the TeleCare North trial’s 
research design and intervention were described. In total, 1,225 COPD patients were 
included in the cluster randomized, controlled trial to either telehealthcare with usual 
practice or only usual practice, depending on the municipality in which the patients 
resided. Telehealthcare consisted of an online data exchange between the patient and 
the healthcare provider. Usual practice involved the existing health care services 
without telehealthcare. The primary outcome was changes in HRQoL at the 
individual level from baseline to 12-month follow-up and the incremental cost-
effectiveness ratio (ICER) measured as the cost per quality-adjusted life year 
(QALY) gained from baseline to 12-month follow-up. The secondary outcomes 
were changes in mortality and physiological parameters from baseline to 12-month 
follow-up.  
[Paper II-VI] Telekit’s usability and the COPD patients’ satisfaction and user 
experiences were evaluated through a series of usability studies. Satisfaction and 
user experiences were assessed using a non-validated questionnaire that was 
developed for the purpose. Various usability evaluation methods were performed on 
Telekit to explore the system’s user-friendliness. The findings of the usability 
studies indicated that the system needed improvement but overall was user-friendly 
and matched the patients’ needs. The findings of the usability studies served as input 
for design improvements and led to significant changes to the Telekit system.  
[Paper VII] Changes in the primary outcome, HRQoL, of the TeleCare North trial’s 
intervention were evaluated. The Short-Form (36) Health Survey was distributed to 
the COPD patients at baseline and after 12 months. Analyses of HRQoL were 
performed using linear mixed models. The findings showed that the changes in 
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HRQoL between groups and subgroups were not statistically significantly different 
from baseline to 12 months. However, the subgroup analysis indicated a trend 
towards a positive effect on HRQoL among certain subgroups of the intervention 
group compared to usual practice.  
[Conclusion] This PhD thesis demonstrated that the telehealthcare system was user-
friendly and that the patients experienced freedom, security, control, and greater 
awareness of COPD symptoms. Poorer HRQoL was not found when the whole 
intervention group was compared to usual practice. Identifiable positive effects may 
exist among subgroups of the intervention group. Further research should be 
conducted to assess the effectiveness of the intervention e.g., by evaluating other 
clinical outcomes and by dividing the patients in subgroups. 
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DANSK RESUMÉ 
[Introduktion] Sundhedsvæsenet står i øjeblikket over for udfordringer i 
behandlingen af kronisk obstruktiv lungesygdom (KOL), hvilket skaber behovet for 
alternative måder at behandle disse patienter på. Telehealthcare kunne være dette 
alternativ. En række studier er blevet udført for at evaluere effekten af 
telehealthcare, men de konkluderer generelt, at der er behov for flere studier i stor 
skala for at opnå tilstrækkelig evidens.  
[Formål] Taget dette i betragtning, var hovedformålet med dette ph.d.-studie at 
evaluere en telehealthcare intervention for patienter, der lider af KOL. Denne 
afhandling havde mere specifikt fokus på: I) at udvikle en studieprotokol for det 
danske stor-skala studie, TeleCare Nord; II) at evaluere studiets telehealthcare-
system (kaldet Telekit) i form af dets brugervenlighed og patientoplevelser; og III) 
at evaluere studiets primære resultat, helbredsrelateret livskvalitet. Disse 
fokusområder er blevet behandlet i syv artikler. 
[Artikel I] En studieprotokol blev udviklet hvori TeleCare Nords forskningsdesign 
og intervention blev beskrevet. I alt blev 1.225 KOL-patienter inkluderet i det 
klynge-randomiserede, kontrollerede studie til enten telehealthcare i tillæg til 
sædvanlig praksis, eller kun til sædvanlig praksis afhængig af, hvilken kommune 
patienterne hørte til. Telehealthcare bestod af online dataudveksling mellem 
patienten og den sundhedsprofessionelle. Sædvanlig praksis involverede det 
eksisterende sundhedsvæsen uden telehealthcare. Det primære resultat var ændringer 
i helbredsrelateret livskvalitet på det individuelle niveau fra baseline til 12 måneders 
opfølgning og den inkrementelle omkostningseffektivitet målt som pris pr. 
kvalitetsjusterede leveår fra baseline til 12 måneders opfølgning. De sekundære 
resultater var ændringer i dødelighed og fysiologiske parametre fra baseline til 12 
måneders opfølgning. 
[Artikel II-VI] Telekits brugervenlighed og KOL-patienternes tilfredshed og 
brugeroplevelser blev evalueret gennem en række usability-studier. Tilfredshed og 
brugeroplevelser blev vurderet ved hjælp af et ikke-valideret spørgeskema, som blev 
udviklet til formålet. Forskellige usability-evalueringsmetoder blev udført på 
telehealthcare-systemet for at undersøge systemets brugervenlighed. Resultaterne af 
usability-studierne indikerede, at systemet skulle forbedres men generelt var 
brugervenligt og matchede patienternes behov. Resultaterne af studierne fungerede 
som input til designforbedringer og førte til væsentlige ændringer i Telekit-systemet. 
[Artikel VII] Ændringer i det primære resultat, helbredsrelateret livskvalitet, af 
TeleCare Nords intervention blev evalueret. Short-Form (36) Health Survey blev 
udleveret til patienterne ved baseline og efter 12 måneder. Analyser af 
helbredsrelateret livskvalitet blev udført ved anvendelse af lineære mixed modeller. 
Resultaterne viste, at ændringerne i helbredsrelateret livskvalitet mellem grupper og 
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subgrupper ikke var statistisk signifikante fra baseline til 12 måneder. Dog 
indikerede subgruppeanalysen en tendens til en positiv effekt på helbredsrelateret 
livskvalitet blandt visse subgrupper af interventionsgruppen sammenlignet med 
sædvanlig praksis. 
[Konklusion] Denne afhandling demonstrerede, at telehealthcare-systemet var 
brugervenligt, og at patienterne oplevede øget kontrol, frihed, tryghed, og større 
opmærksomhed på KOL-symptomer. Dårligere livskvalitet blev ikke fundet, når 
hele interventionsgruppen blev sammenlignet med sædvanlig praksis. Identificerbare 
positive effekter kan eksisterer blandt subgrupper af interventionsgruppen. Der bør 
udføres yderligere forskning for at kunne vurdere effekterne af interventionen, fx 
ved at evaluere andre kliniske resultater og ved at inddele patienterne i subgrupper. 
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PREFACE 
This PhD thesis is submitted to Aalborg University in fulfillment of the requirement 
for the degree of Doctor of Philosophy. The thesis presents the results of the 
scientific work that I have carried out in the period from 2013-2016 at the 
Department of Health Science and Technology, Aalborg University, Denmark. The 
PhD thesis is based on original work, except where references are represented. The 
PhD study was supervised by Professor Ole K. Hejlesen and co-supervised by 
Professor Lars H. Ehlers.  
My motivation for this work comes from my general interest in the healthcare field 
and my experiences of working as a nurse. I started working within the 
telehealthcare area during my Master´s program and found a particular interest in 
helping to optimize the yield of various technological advances by identifying and 
documenting the need for new technologies. When I started my PhD, I was very 
enthusiastic about making a mark on telehealthcare to optimize the healthcare 
services and provide better treatment for patients.  
During the period of my PhD, I had the opportunity to meet other fellow researchers 
and to present my research at Conferences in Madrid (Spain), Copenhagen 
(Denmark), Aalborg (Denmark), and Istanbul (Turkey). I also enjoyed supervising 
students in their projects in Medicine, Industrial Medicine, Biomedical Engineering, 
and Clinical Science and Technology.  
This PhD study is based on a large-scale, Danish trial, named TeleCare North, which 
was launched in the North Denmark Region in January 2012. The trial aimed to 
develop and implement a telehealthcare system, Telekit, for patients suffering from 
COPD. The TeleCare North trial was funded by the North Denmark Region; the 
municipalities in the North Denmark Region; the Obel Family Foundation; the 
Danish Agency for Digitalization Policy and Strategy; and the European Social 
Fund. Four PhD activities were affiliated with the trial: a health economics PhD 
scholarship (Flemming Witt Udsen); a health literacy-based PhD scholarship (Lisa 
Korsbakke Emtekær Hæsum); an organizational theory PhD scholarship (Jannie 
Kirstine Bang Christensen); and a health- and patient-related PhD scholarship 
(Pernille Heyckendorff Lilholt).  
All data for this PhD study are obtained from the TeleCare North trial. I began by 
gathering information about the conception of the TeleCare North trial and by 
determining the choice of appropriate methods and tools to evaluate the trial’s 
intervention. Inclusion and exclusion criteria for patient selection were established 
in cooperation with the trial’s Administration Office and other health professionals. 
Baseline data were measured by clinicians, and PhD students (including myself) 
were responsible for the data collection and data processing in the trial’s assessment 
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period. During my PhD study, I evaluated the trial’s telehealthcare system through 
an iterative process and provided feedback regarding Telekit’s usability to the 
system developers. The trial’s protocol and statistical analysis have been carried out 
through collaboration with Flemming Witt Udsen, who has a strong background in 
statistics.    
The content of the thesis consists of seven papers that were written during my PhD 
studies. In addition to these papers, this thesis is divided into seven chapters with the 
following contents:  
Chapters 1-2: Introduction and background to the research topic 
Chapter 3: Overview of the structure of the PhD thesis supplemented with research 
aims and questions 
Chapter 4: Summary of each paper’s aim, methods, results, and 
discussion/conclusion 
Chapter 5: The seven papers in full text 
Chapter 6: General interpretation and discussion of the main findings of the PhD 
thesis in which the strengths and weaknesses are considered together with 
suggestions for future research 
Chapter 7: Conclusion that summarizes the main results of the PhD thesis 
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CHAPTER 1. INTRODUCTION 
1.1. RATIONALE FOR THIS PHD STUDY 
The healthcare system is under pressure due to demographic changes that indicate 
that the population is getting older and living longer (8,9). As a consequence, the 
number of chronic diseases in the population is increasing, which results in a 
growing need for more health services and thus rising healthcare costs and increased 
workload for the healthcare system (10).  
To address some of these challenges, other alternatives have been considered to 
undertake the treatment and care of chronic patients (11). Policy makers and 
healthcare stakeholders have high expectations for telehealthcare as a central 
component of establishing a capable and more efficient health care system that can 
meet some of the challenges the health care system will have to face in the future. 
Telehealthcare can be a significant component of how care will be managed in the 
future, but it has yet to be widely accepted as a sustainable choice due to the lack of 
evidence regarding its effectiveness and cost-effectiveness (12). Reviews (13,14) 
have noted that the benefits of telehealthcare are not yet proven, and limited 
evidence is available concerning its use-value, which calls for larger scale studies.  
The lack of large-scale Danish studies on telehealthcare has for many years been a 
barrier to the implementation of telehealth in Denmark. In 2012, the Government, 
Danish Regions, and Local Government Denmark created an ambitious National 
Action Plan for the Dissemination of Telemedicine (15,16). The Action Plan (15,16) 
should support and spread initiatives that could provide valuable experiences 
regarding the use of telehealth in chronic diseases. One of these initiatives included 
the establishment of a large-scale trial, TeleCare North in the northern part of 
Denmark. TeleCare North was implemented in the North Denmark Region between 
2012 and 2015 to improve the body of evidence and to serve as a national standard 
for implementing telehealthcare in Denmark. TeleCare North intended to provide 
evidence of the effectiveness and cost-effectiveness of telehealthcare in patients 
suffering from COPD [Paper I].  
This PhD study was compiled in association with the TeleCare North trial. The 
research presented in this thesis contains a description of the TeleCare North trial’s 
intervention and an evaluation of its outcomes regarding health-related quality of 
life (HRQoL), usability and patients’ experiences. This PhD thesis includes: I) a 
description of the TeleCare North trial’s research design and intervention; II) a 
usability evaluation of the telehealthcare system adopted in the TeleCare North trial; 
and III) an outcome evaluation of the TeleCare North intervention assessing the 
changes in HRQoL. 
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CHAPTER 2. BACKGROUND 
In this chapter, relevant background information will be presented about COPD and 
telehealthcare. This information is followed by a description of the current evidence 
on telehealthcare, how telehealthcare interventions can be evaluated regarding 
effectiveness and usability, and the TeleCare North trial. The chapter ends with a 
summary of the background that will lead to the scope of this PhD study. 
2.1. CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
2.1.1. EPIDEMIOLOGY 
COPD is a very common, progressive condition – both worldwide and in Denmark. 
The prevalence of COPD is estimated to be 11.7% worldwide (17) and 7% in 
Denmark (18). Approximately 436,000 Danes have COPD, of whom 166,000 have 
mild COPD, 230,000 have moderate COPD, and 40,000 have severe COPD (18). 
The high prevalence and the nature of the disease lead to, in Denmark (annual means 
from 2010-2012), 17,000 admissions, 3,400 emergency department visits, 65,000 
out-patient visits, and 490,000 extra visits at the general practitioner (GP) (19). 
COPD is costly for the Danish healthcare system and costs up to 3 billion Danish 
crowns annually in hospital expenditures (exclusively medical expenses), equivalent 
to 10% of the total expenditure for individuals over 40 years. Furthermore, the 
expenditure for COPD is larger than those of other chronic diseases (20).  
The disease is one of the leading causes of morbidity and mortality because many 
people suffer from COPD for years and die prematurely from the illness or its 
complications (21). More than 3 million people died of COPD worldwide in 2005 
(22), and COPD is annually the cause of 3,500 deaths in Denmark (23). At present, 
the disease is the fourth leading course of deaths worldwide and is predicted to be 
the third leading cause of death in 2030 (24).  
2.1.2. CHARACTERISTICS OF COPD 
COPD is an umbrella term that describes progressive lung diseases including 
chronic bronchitis and emphysema. COPD is characterized by a persistent airflow 
limitation that is usually progressive and associated with an increased chronic 
inflammatory response in the airways and the lungs to noxious particles or gasses 
(21). COPD is a progressive disease in which the symptoms are slowly expressed 
without the patient necessarily noticing them in everyday life. The patients become 
accustomed to the symptoms leading to the illness often being diagnosed at an 
advanced stage (25). The common symptoms of COPD include chronic progressive 
dyspnea, cough, and sputum production. Many patients with COPD experience 
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variations in their symptoms throughout the day. Others experience discomfort most 
of the time (26).    
2.1.3. ETIOLOGY 
Smoking tobacco (including second-hand or passive exposure) is the primary cause 
of COPD in high- and middle-income countries. Risk factors also include indoor air 
pollution such as biomass fuels for cooking and heating and long-term exposures to 
dust, toxic gases, and chemicals. These risk factors often occur in low-income 
countries as a result of poorly ventilated homes and poor working conditions (27). 
Some genetic factors can also increase the vulnerability of the lungs to developing 
COPD. The most important is a hereditary condition in which there is insufficient 
production of the protein alpha-1-antitrypsin. Alpha-1-antitrypsin provides a natural 
defense mechanism against the persistent lung inflammation that can lead to 
emphysema and COPD. People who suffer from this condition can develop severe 
COPD within 40 years of age if they smoke (28). Another risk factor involves 
frequent lung infections in early childhood, which can lead to impaired development 
of the lungs and predispose individuals to an increased risk of COPD as an adult. 
There are a number of other factors in addition to lung infections in childhood such 
as low birth weight that predispose individuals to COPD in adulthood, and low 
social status is also associated with an increased risk of COPD (27).     
2.1.4. PATHOLOGY AND PATHOPHYSIOLOGY 
In COPD, changes in the lung tissue are identified in the large and small airways 
that jointly cause a variety of signs and symptoms that characterize the disease. 
COPD patients have different degrees of pathological changes in the airways 
(chronic bronchitis) and the alveoli (emphysema). The considerable variation in 
these changes among the various patients partly explains the different clinical 
manifestations of COPD (29).  
In COPD, there is constriction of the airway lumen and obstruction not only due to 
the airway inflammation and an accumulation of secretion but also because of the 
destruction of the small terminal airways. The inflammation of the respiratory tract 
extends from the epithelium through the entire wall, with more goblet cells in the 
epithelium, more mucus-producing glands, hypertrophy of the smooth muscle cells, 
infiltration of the mucosa with inflammatory cells and fibrosis (30).   
Destruction of the alveoli leads to the loss of lung tissue connections to the 
respiratory tract and contributes to the collapse of the bronchioles due to the lack of 
sufficient elasticity to keep the airways open – this observed particularly during 
expiration (31). Parallel to the chronic airway inflammation is the identified atrophy 
of the pulmonary vessels and capillaries. These changes can lead to pulmonary 
hypertension and cor pulmonale in severe cases. The process of inflammation may 
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be complicated by bronchiectasis, trachea-bronchomalacia and fibrotic changes in 
the airways and the lung parenchyma (32). The pathological changes result in 
reduced FEV1 (forced expiratory volume) over time and the following physiologic 
abnormalities and symptoms: airway limitations and air trapping, gas exchange 
abnormalities, mucus hypersecretion, pulmonary hypertension, exacerbations, and 
systemic features (21). This PhD thesis does not focus on the COPD pathology and 
pathophysiology, which is why they are not further described.  
Exacerbations 
Patients with COPD in the advantaged stage of the disease experience exacerbations 
that are an acute worsening of usual symptoms and often require hospitalization and 
changes in the patient’s standard treatment (21). The symptoms that are often 
present during exacerbations include increased dyspnea, productive cough, fever, 
and increased sputum with changes in color (33). The causes of these exacerbations 
are mostly viral or bacterial infections, which are especially frequent in COPD 
patients because of the reduced capacity of their lungs to remove mucus. However, 
other causes such as environmental pollutants, psychological influences or unknown 
factors can also lead to exacerbations (34,35).    
Exacerbations are strongly linked to worse health, more depressive symptoms and 
accelerations in the decline of lung function. Furthermore, exacerbations are 
strongly associated with mortality and morbidity. Early treatment of exacerbations is 
important for the possible outcome of the patient. Approximately 50% of all 
exacerbations have been estimated to be reported to the healthcare system. This 
under-estimation could be due to the patients’ differing perceptions of the 
implications of an exacerbation (25).  
Comorbidities 
Among patients with COPD, there is an increased incidence of other diseases, i.e., 
comorbidities, which can affect their prognosis, quality of life (QoL), exacerbations, 
and treatment (36). The most important comorbidities include cardiovascular 
diseases, musculoskeletal disorders, osteoporosis, lung cancer, and mental illnesses 
such as depression and anxiety (37). The comorbid conditions increase the 
occurrence of exacerbations, the risk of hospital stays for COPD, and have a strong 
influence on mortality. Thus, comorbidities increase the difficulty of managing 
COPD and should therefore be treated routinely and appropriately (38,39).   
2.1.5. DIAGNOSIS OF COPD  
The COPD diagnosis is established based on smoking and medical history, 
symptoms, risk factors, and spirometry results. The lung function test, spirometry, is 
the cornerstone of the diagnosis, monitoring, and staging of COPD, as well as of the 
exclusion of the main differential diagnosis, asthma. The spirometry test measures 
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values of forced expiratory volume in the first second (FEV1), forced vital capacity 
(FVC), and the FEV1/FVC ratio of these measures.  
COPD is defined by an impaired lung function of the obstructive type, i.e., forced 
expiratory volume in one second (FEV1)/forced vital capacity (FVC) < 70%, which 
is not entirely reversible (21). The FEV1/FVC ratio is between 0.70 and 0.80 in 
healthy adults (40). The FEV1 value in terms of the % of the predicted FEV1 value 
is determined based on age, sex, height, and race and is used to classify the severity 
(mild, moderate, severe, and very severe) of COPD. The staging is used to 
determine the treatment strategy (21).  
In addition to spirometry, other various clinical examinations are used to assess the 
diagnosis of COPD. These examinations will not be further described but include, 
for example, chest x-ray, sputum culture, arterial puncture for blood gas analysis, 
CT scan of the thorax, and pulse oximetry (41).   
2.1.6. COPD ASSESSMENT TOOLS 
In addition to the spirometric diagnosis and the other clinical examinations, it is 
important to consider patient-reported symptoms to obtain an adequate overview of 
the COPD patient’s condition. The assessment of COPD is based on the patients’ 
symptoms, the risk of exacerbations, the degree of airflow limitation (spirometry), 
and the identification of comorbidities (42). 
Medical Research Council Dyspnea Modified Scale 
Patients’ symptoms can be measured using the Medical Research Council modified 
scale (mMRC), which is a validated tool that has been translated into Danish. The 
scale is of use in clinical practice, and the scores accurately express the patient’s 
prognosis and the necessity of medication and rehabilitation. The mMRC scale is 
based on the patients’ description of their degree of shortness of breath (21,43,44). 
Table 1 shows the mMRC scale, which comprises five statements of the extent of 
breathlessness related to activity.  
Table 1: The mMRC scale includes five statements that quantify the disability associated with 
breathlessness (21).   
The mMRC Breathlessness Scale 
mMRC 0 I only get breathless with strenuous exercise 
mMRC 1 I get short of breath when hurrying on the level or walking up a slight hill 
mMRC 2 I walk slower than people of the same age on the level because of breathlessness, or I have 
to stop for breath when walking on my own pace on the level 
mMRC 3 I stop for breath after walking about 100 meters or after a few minutes on the level  
mMRC 4 I am too breathless to leave the house, or I am breathless when dressing and undressing 
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The COPD Assessment Test 
The COPD Assessment Test (CAT) is an 8-item questionnaire that measures the 
level of health status impairment in COPD. The questionnaire is suitable for all 
patients with COPD and should be used in the clinical assessment of patient’s 
COPD to achieve the optimal management of the disease. The CAT score ranges 
from 0-40, with higher scores denoting a more severe impact of COPD on a 
patient’s life (45).   
The Global Initiative for COPD 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) is a 
collaboration between the National Heart, Lung, and Blood Institute, National 
Institutes of Health, USA, and the World Health Organization. GOLD has produced 
some guidelines to support healthcare providers and clinicians in the treatment, 
stratification, and assessment of COPD (21). Table 2 illustrates GOLD’s Spirometric 
Assessment Classification that stratifies patients according to their degree of airflow 
limitation. This spirometric classification (I-IV) was used in Paper VII to categorize 
the patients from the TeleCare North trial based on their disease severity. 
Table 2: GOLD’s Spirometric Assessment Classification, which classifies people with COPD 
based on their degree of obstruction (21). 
Stages of COPD Fixed ratio Severity of airflow limitation 
Mild (I) FEV1/FVC < 70% FEV1 ≥ 80% predicted 
Moderate (II) FEV1/FVC < 70% 50% ≤ FEV1 < 80% predicted 
Severe (III) FEV1/FVC < 70% 30% ≤ FEV1 < 50% predicted 
Very Severe (IV) FEV1/FVC < 70% FEV1 < 30% predicted 
 
GOLD has since updated its guidelines and suggested other COPD staging criteria 
because the spirometric classification (I-IV) only considers the patients’ degree of 
airflow limitation and does not account for other symptoms and factors. FEV1 is a 
poor predictor of disease status alone, which has led to GOLD’s development of 
combined risk assessment scores that include the patients’ symptoms, 
breathlessness, spirometric assessments, and/or risk of exacerbations (21). Table 2 
shows GOLD’s Combined COPD Assessment Classification, which categorizes 
patients into four groups (A-D) according to disease severity. 
Table 3: GOLD’s Combined COPD Assessment Classification, which categorizes patients 
based on symptoms, exacerbation history, and airflow obstruction (21). 
Stages of COPD Combined assessment of COPD  
Low risk, low 
symptom burden (A) 
Low symptom burden (mMRC 0-1 OR CAT > 10) AND FEV1% ≥ 50 AND 
Low exacerbation rate (0-1/year) 
Low risk, higher 
symptom burden (B) 
Higher symptom burden (mMRC ≥ 2 OR CAT ≥ 10) AND FEV1% ≥ 50 AND 
Low exacerbation rate (0-1/year) 
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High risk, low 
symptom burden (C) 
Low symptom burden (mMRC 0-1 OR CAT < 10) AND FEV1% < 50 
AND/OR high exacerbation rate (≥ 2/year)  
High risk, higher 
symptom burden (D) 
Higher symptom burden (mMRC ≥ 2 OR CAT ≥ 10 AND FEV1% < 50 
AND/OR high exacerbation rate (≥ 2/year) 
 
Vital signs 
Measuring vital signs such as blood pressure, heart rate, oxygen saturation, and 
weight is also important in assessing disease progression in COPD. These vital signs 
can be measured at home, in clinical settings or elsewhere by different devices such 
as pulse oximeters and blood pressure monitors. If the vital signs differ from the 
usual, this may indicate progression of COPD (46,47).   
Relevant markers and tools other than those mentioned in this thesis are available 
for the assessment of COPD (48). The above assessment tools were used to measure 
a set of inclusion criteria for the TeleCare North trial. This trial will be presented 
later in this chapter of the thesis.  
2.1.7. TREATMENT OF COPD IN DENMARK  
In Denmark, the entity responsible for the detection, diagnosis, treatment, and 
follow-up of COPD patients is to a large extent general practice, particularly in 
patients with mild to moderate COPD. Usually, patients’ GPs follow them 
throughout the course of the disease and act as the patients’ coordinators. Patients 
have to be referred by their GP to consult a pulmonologist at the hospital, but all 
have equal access to health care services, including being examined and treated by a 
GP or at a public hospital. People can use health services regardless of their 
financial situation or insurance conditions because the healthcare system is almost 
100% publicly financed through taxes (49). In many other countries, health benefits 
are not tax-financed and are payable by individuals when using a service. In the 
TeleCare North trial, the patients allocated to the control group received the existing 
healthcare treatment. 
Pulmonary rehabilitation is well-documented as an effective component of the 
treatment of COPD (50). The aim is to provide the individual COPD patient the 
opportunity to achieve the highest possible functional capacity and quality of life. 
Pulmonary rehabilitation  is indicated by an MRC score ≥ 3, and the rehabilitation 
should include the following elements (51):  
Nicotine replacement therapy: Patients are offered a motivational conversation and 
assistance in stopping smoking as well as information about the damage caused by 
tobacco consumption. Smoking cessation is the most effective intervention against 
COPD to prevent disease progression and reduce future health care costs (51). 
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Exercise training: Patients are advised of the importance of physical exercise, 
especially aerobic training, as a part of rehabilitation. Patients’ functional levels 
decrease concurrently with the progression of the disease, resulting in a more 
sedentary lifestyle and poor conditioning, with deterioration in respiratory 
symptoms. The purpose of the exercise is to provide patients with the best possible 
starting point to account for this progression (51). 
Pharmacological therapy: Medical treatment is a prerequisite for the rehabilitation 
of COPD, and its purpose is to improve the patient’s health conditions and minimize 
their symptoms of COPD. The treatment varies depending on the severity of the 
disease and whether the patient is in a stable or acute phase of illness. In the stable 
phase, all patients regardless of their severity of COPD receive vaccination against 
influenza and short-acting bronchodilators as needed to reduce their short-term 
symptoms. Patients with moderate to severe COPD are permanently treated with 
long-acting bronchodilators, while patients with severe to very severe COPD are 
offered steroid inhalants if repeated exacerbations are experienced. Oxygen therapy 
is offered to patients with severe COPD. A distinction is made between short- and 
long-term oxygen therapy. Long-term therapy is used in connection with acute 
exacerbation of COPD during hospitalization at a hospital or in the ensuing weeks. 
Long-term oxygen therapy is permanent, continuous oxygen therapy (at least 15 
hours a day). Treatment leads to improved survival and enhances patients’ quality of 
life; they are more energetic and awake and can manage several activities (51).   
Education on COPD: COPD patients are taught with the aim of strengthening their 
autonomy, action competence, and quality of life by providing information about the 
disease itself and its corresponding prevention and rehabilitation. The effects of 
minimal exposures to risk factors, especially tobacco consumption, are emphasized, 
and the patient is informed about management of acute exacerbations. The education 
helps patients to participate actively in the treatment and rehabilitation of their 
disease in collaboration with the healthcare system and allows patients to take 
responsibility for their illness (51).   
Emotional support: COPD is associated with social isolation, anxiety, and 
depression. Emotional support aims to prevent the development of mental disorders. 
The risk of anxiety and depression increases with the progression of the disease and 
increased shortness of breath. The patient’s psychosocial conditions are attempted to 
be assessed, and appropriate support and relief measures are offered such as 
specialist referrals, patient associations or family support (51).  
Nutrition counseling: The aim of nutrition counseling is to ensure that the patient 
maintains an optimal nutritional status and an adequate weight relative to their 
disease condition. Patients who are underweight receive individual guidance and 
nutritional therapy to increase their body weight. In contrast, patients who are obese 
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are recommended to reduce their body weight and are offered diet and regular 
weight control strategies (51).  
 
2.1.8. THE CONSEQUENCES OF COPD 
The global burden of COPD could increase due to demographic changes that 
indicate that the average life expectancy will increase in the future. These changes 
would lead to an increase in the number of elderly needing care and an increase in 
the number of chronic diseases, which ultimately also implies significant increases 
in health care expenditures (52). The socio-economic costs are associated with the 
treatment and care of COPD and the society’s loss of production due to COPD 
patients’ untimely deaths and withdrawal or absence from the labor market 
(27,53,54). The patient-related costs are related to the discomfort or disability that 
the disease causes, with reduced quality of life as a consequence (55). Consequently, 
the disease constitutes a major health challenge for the individual and for society. 
The growing elderly population with several chronic diseases causes an increased 
demand on the healthcare system and thus the need for more efficient treatments. 
Additionally, it appears that the costs of COPD will increase in the future, which 
make it appropriate to prevent and treat COPD for both human and economic 
reasons (56).  
2.2. TELEHEALTH AS A POTENTIAL SOLUTION 
The healthcare challenges described above can be addressed by making better use of 
resources and by delivering health services in new ways. COPD is treated with the 
aim of reducing symptoms and preventing disease progression and exacerbations. 
The identification and treatment of the disease before any exacerbations occur may 
lower the morbidity, mortality, comorbidity, healthcare utilization, and costs and 
improve health- and patient-related outcomes (56). Telehealth is a potential answer 
to providing efficient and safe healthcare by using it as a service in the management 
of COPD (57,58); some feasibility studies have already assumed that telehealth has 
a favorable value concerning quality of life compared to standard care (59–63).  
Different terminologies  
The term “telehealth” does not have a consistent definition across the literature and 
is often used interchangeably with the terms “telemedicine”, “telecare” and 
“eHealth” (64,65). However, there exist certain substantial differences between the 
terms (66):   
The World Health Organization (WHO) defines telehealth as follows:  
“the delivery of health care services, where patients and providers are 
separated by distance. Telehealth uses ICT for the exchange of information 
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for the diagnosis and treatment of disease and injuries, research and 
evaluation, and for the continuing education of health professionals. 
Telehealth can contribute to achieving universal health coverage by 
improving access for patients to quality, cost-effective, health services 
wherever they may be. It is particularly valuable for those in remote areas, 
vulnerable groups and aging populations” (67) 
In the Whole System Demonstrator Project (WSD), the English physician and expert 
in Health Informatics, Stanton Newman, adopts the following detailed definition of 
telehealth:  
“Telehealth requires active participation of patients to measure vital 
signs using peripheral devices whereas telecare monitors without the 
need for patient input” (68)  
“Telehealth differs in that it allows the remote exchange of data between 
a patient (at home) and health care professionals (at a Monitoring 
Centre) to assist in the management of existing long-term conditions 
(chronic obstructive pulmonary disease, diabetes, heart failure)” (68) 
“Telehealth” is especially often used in connection with “telecare,” as these two 
concepts complement each other.  
Stanton Newman defines telecare as: 
“TeleCare describes a system that allows remote and automatic monitoring 
that does not require any active involvement of individuals’ personal health 
and safety (e.g. mobility, falls) and home environment (e.g. floods, fires) in 
order to manage the risks of independent living or provide prompt emergency 
responses” (68) 
“Telehealthcare” is composed of the two concepts, “telehealth” and “telecare”, and 
the conceptualization of telehealthcare defined by Doctor Susannah McLean is as 
follows:  
“the provision of personalized health care from a distance” (5) 
This description comprises the following key considerations:  
“Information is obtained from individual patients, for example, in the 
form of a symptom score, oxygen saturation level, pulse rate” (5) 
“These data are transmitted over a distance by information and 
communication technology” (5) 
EVALUATION OF A TELEHEALTHCARE INTERVENTION FOR PATIENTS WITH COPD 
32
 
“A healthcare professional then exercises their clinical skills and 
judgment in interpreting this information and actively provides the 
patient with personalized feedback” (5) 
This PhD research preferentially uses the term “telehealthcare” throughout the thesis 
because the telehealthcare system utilized in the TeleCare North trial involves active 
patient participation, with COPD patients measuring their vital signs using an 
asynchronous application with peripheral devices. The TeleCare North trial and its 
system will be described later in this chapter.  
Types of telehealthcare  
Telehealthcare can be divided into three main types of applications covering store-
and-forward, remote monitoring, and real-time interactive services: 
Real-time services: This type is also known as synchronous telehealth, in which 
information is sent from the originating site to the receiving site as it occurs, rather 
than being stored for later transmission. Real-time telehealth services are used to 
consult, diagnose or treat patients and require the involved individuals to be present 
at the same time (69,70).  
Store-and-forward services: This type is also known as asynchronous telehealth; in 
it, the transmission of information can be sent to the specialist at a suitable time for 
evaluation offline. The information can be stored in a specific format and sent to 
healthcare providers for a diagnosis, a confirmatory or second opinion or any other 
reason. This type of application does not require the involved individuals to be 
present at the same time, and the transmission typically occurs in one direction. An 
asynchronous telehealthcare application was used in the TeleCare North trial 
(69,70). 
Remote monitoring services: This type is also called self-monitoring and relies on 
the patients using these various forms of technologies to test and monitor themselves 
from their home. Remote monitoring is often used in the treatment of chronic 
conditions, such as COPD and heart disease (69,70). 
Advantages and disadvantages of telehealthcare 
Telehealthcare’s main benefit is its possibility of providing consultations between 
healthcare providers and patients without any geographic boundaries. Telehealthcare 
has many other potential benefits such as the following: 
 
 Decreased travel time or distance and removal of travel barriers 
 Enhanced access to health care services 
 Early detection of disease processes or health issues 
 Better communication between providers 
 Ownership of healthcare and feelings of empowerment  
 Long-term health and independence 
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 Caregiver reassurance  
 Patient satisfaction with health care (71,72) 
 
Despite the several advantages of telehealthcare, some potential drawbacks also 
deserve to be mentioned:  
 
 A disintegrated relationship between healthcare providers and patients 
 A disintegrated relationship between healthcare providers  
 Concerns about the quality of health information 
 Complications of organizational and bureaucratic character (73) 
 
Despite telehealthcare’s many potential advantages in managing chronic conditions, 
the evidence regarding its benefits, costs, and acceptance seems not to be determined 
yet. 
2.2.1. CURRENT EVIDENCE ON TELEHEALTHCARE 
A number of systematic reviews and meta-analyses suggest that telehealthcare can 
be effective in improving quality of life and health outcomes and may also result in 
cost reductions (5,74). However, there seems to be some degree of agreement that 
the evidence on the effects of telehealthcare remains limited and that there is still a 
need for further robust research within this field (14,75–79). The evidence is 
questioned due to the large number of pilot studies and mixed quality trials with 
diverse outcomes and limited numbers of patients. Most reviews claim that clinical 
heterogeneity is present in most outcomes of interest, which is primarily due to the 
different study populations (e.g., variation in diseases, disease severity, age), 
different interventions, different technologies, and different study designs (e.g., 
RCTs versus observational studies), which make it difficult to determine the effects 
of telehealthcare based on these outcomes (80–82).  
The reviews address the methodological limitations of the current studies and 
provide suggestions for strengthening the evidence base, both regarding cost-
effectiveness and effectiveness (83–86). The reviews generally conclude that more 
evidence is needed from large RCTs of appropriate rigor and quality (80). Studies 
with longer follow-up periods are necessary to gain knowledge about the long-term 
effects and the sustainability of telehealthcare (87). Some reviews discuss the need 
for studies to include technical, ethical, organizational, and economic effects in 
addition to clinical effectiveness (74,86,88–90). More knowledge is also necessary 
to identify which patient groups are most likely to benefit from telehealthcare 
(91,92), and what types of devices or services are most effective (93). Thus, the 
answer to whether telehealthcare is effective remains uncertain (5).   
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2.2.2. EVALUATION OF TELEHEALTHCARE 
Effectiveness of telehealthcare 
Evaluations of interventions can provide evidence regarding the effectiveness of 
telehealthcare and support stakeholders and policy makers in decision-making 
regarding best practices. Effectiveness addresses issues such as “Does the 
intervention work?” and “Who will benefit from its use?” (1) Telehealthcare might 
be a solution to the management of chronic illnesses but as with all types of health 
technologies, it is required that the technologies demonstrate user usefullness, 
effectiveness, and cost-effectiveness before telehealthcare can be fully implemented 
(94). Telehealthcare has been reported to produce the same or even better clinical 
outcomes compared with existing conventional care, but we do not know whether 
these reports are true. An evaluation of the outcomes of care delivered through 
telehealthcare compared with the outcomes delivered through conventional 
treatment will provide information about the effectiveness of telehealthcare.  
In Medical Informatics, the gold standard for research and evaluation is the 
randomized controlled trial (RCT) (1,95,96). In the RCT design, subjects are 
randomly allocated to intervention or control groups and, if possible, are blinded to 
the treatment procedure. RCTs are considered the most robust method to establish 
cause and effect relationships (97). A cluster-RCT is a type of RCT in which groups 
of subjects, rather than individuals, are randomized to an intervention and control 
group (98). A cluster-RCT was chosen as the research design of the TeleCare North 
trial. 
In the evaluation of telehealthcare interventions, a range of reliable and validated 
outcomes may be selected, with the goal of establishing evidence of the value of 
telehealthcare (99). These outcomes can be based on clinical effectiveness, patient 
perspectives, economic and organizational aspects, etc. (100). The goal of caring for 
chronically ill patients with COPD is not to cure them but rather to increase their 
quality of life. Thus, QoL can be a suitable outcome measure for assessing whether 
telehealthcare is the same as or is better than existing treatments for COPD patients 
(101,102). Many validated, generic or disease-specific QoL outcome tools have 
been developed. A patient-reported QoL outcome tool that is commonly used to 
evaluate health-related quality of life (HRQoL) is the Short-Form Health Survey 
(SF-36) (103,104). HRQoL includes four core domains (3), which are depicted in 
Figure 1. 
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Figure 1: The core domains included in the assessment of multi-dimensional HRQoL (3). 
The SF-36 is a generic 36-item questionnaire that is not addressed to a specific age 
group, disease group or treatment group. The survey measures eight domains that 
cover functional health and well-being from the patients’ perspective. The eight 
domains include physical functioning, role limitations due to physical health, role 
limitations due to emotional problems, energy/fatigue, emotional well-being, social 
functioning, pain and general health. An aggregated percentage score that ranges 
from 0% (lowest HRQoL) to 100% (highest HRQoL) is produced for each of the 
eight domains. Two summary scores of physical HRQoL (Physical component 
summary score; PCS) and emotional HRQoL (Mental component summary score; 
MCS) can also be generated by calculating the mean average of all of the physically 
relevant questions and all of the emotionally relevant questions, respectively. The 
SF-36 is a useful indicator of change in HRQoL over time and during treatment, 
with an increase in scores indicating an improvement in HRQoL (104). The 
questionnaire was used as the primary outcome measure of effectiveness in the 
evaluation of the TeleCare North trial.  
Usability in telehealthcare 
Usability is an essential element in the successful implementation of telehealthcare 
and can contribute to the effectiveness of such interventions and to ensuring the 
benefits of telehealthcare technologies (105). The International Organization for 
Standardization (ISO) defines usability as follows:  
“The extent to which a product can be used by specified users to achieve 
specified goals with effectiveness, efficiency, and satisfaction in a specified 
context of use” (6) 
HRQoL
Physical
Emotional
Social
Functional
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Poor usability reduces the acceptance of telehealthcare systems, and the potential 
benefits of telehealthcare could fail if the users cannot easily or efficiently use these 
systems to meet their needs (106). Therefore, usability in telehealthcare is important 
but has frequently been ignored by designers and evaluators. Much attention has 
been paid to the technical aspects of telehealthcare, and less focus has been on its 
usability aspects. Most often, the design of telehealthcare systems has been limited 
by the requirements of the clinical users, healthcare providers, and the equipment 
vendor (107). System development requires the involvement of all users, with their 
physical limitations, environments, activities, abilities, and skills being taken into 
account (108). The following requirements should be fulfilled by telehealthcare 
according to Botsis and Hartvigsen (109): telehealthcare should be simple to use, 
operate without interruptions and provide computer security and data confidentiality 
(109).  
The design of telehealthcare systems should be usable and acceptable, and ensuring 
usability can be challenging because it is typically elderly people with limited 
functional status and skills who will be using these technologies (110,111). As 
telehealthcare systems might be challenging, especially for older people who may 
have limited capabilities, it is important to explore their use of and experiences with 
these types of technologies (112,113). The ISO defines user experiences as:  
“A person's perceptions and responses that result from the use and/or 
anticipated use of a product, system or service” (7) 
User experiences can be measured with psychometric questionnaires (114) and by 
the system’s usability and can be verified and tested through tests and evaluations to 
ensure that the users remain central to the design process of a system and that 
usability is designed into the system (115). The two standard methods of measuring 
usability are inspection methods performed by experts and empirical testing 
conducted by representative users (116,117). The telehealthcare system used in the 
TeleCare North trial was evaluated by using both types of usability testing methods 
(see Paper II-VI) to assess the user-friendliness of the system. 
2.3. PRESENTATION OF THE TELECARE NORTH TRIAL 
In 2012, the Government, Danish Regions, and Local Government Denmark framed 
an ambitious National Action Plan for Dissemination of Telemedicine (15,16). The 
Action Plan included five initiatives (projects) that were intended to ensure that 
telemedicine was tested in a large-scale context and in areas of the healthcare service 
in which there was sparse documentation of the effects of this form of care. A total 
of DKK 80 million (Approx. 11 million EUR) were invested to finance these five 
initiatives of the Action Plan to establish a better framework for telemedicine 
(15,16). One of these five initiatives was the Danish TeleCare North trial 
(www.telecarenord.dk), which was expected to acquire the experiences of 
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implementing telehealthcare at a large scale. The ambition was that given the 
TeleCare North trial, it would be possible to establish common national models and 
strategies for how telehealthcare solutions, both technically and cross-
organizationally, should be implemented and organized (118).  
In this section, the TeleCare North trial will be briefly presented. For more detailed 
information about the trial, see the trial protocol (Paper I) or Chapter 3 (Section 3.1.: 
Context of the PhD study). 
The TeleCare North trial was implemented between 2012 and 2015 and was 
established as a cross-sectional cooperation between the North Denmark Region, 
Aalborg University, and the municipalities, hospitals and general practitioners in the 
Region [Paper I]. The TeleCare North trial was based on the results of small pilot 
studies such as the previous Danish research project, TeleKat, which was targeted to 
patients with COPD (119). TeleKat showed that telerehabilitation had both positive 
patient-related and economic effects, with a reduction observed in hospital 
admissions, number of out-patient visits, home care services and average length of 
stay (120). An improvement was found in patient empowerment (121) and their 
achievement of feeling safe at home (92).  
The TeleCare North trial was the first pragmatic, randomized, controlled large-scale 
trial in Denmark. The trial had two main purposes: 1) to evaluate the effectiveness 
and cost-effectiveness of telehealthcare in comparison with usual practice and 2) to 
obtain knowledge about the management and organizational implications of 
telehealthcare at a large scale (119). In total, 1,225 (578 intervention, 647 control) 
COPD patients were randomly allocated to either telehealthcare in addition to usual 
practice or only usual practice. The intervention patients were assigned to the 
telehealthcare system (coined Telekit), and the control group was assigned to the 
existing conventional treatment of COPD. Figure 2 illustrates the research design of 
the TeleCare North trial using a basic flow diagram.   
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Figure 2: The TeleCare North trial's research design with the process of identification, 
allocation, and randomization of patients. 
2.3.1. THE TELEHEALTHCARE SYSTEM, TELEKIT 
The telehealthcare system, Telekit, was developed by Silverbullet, Aarhus, Denmark 
(http://opentele.silverbullet.dk) with the aim of supporting patients in coping with 
their chronic disease. The basic logic behind the system was that by improving the 
patients’ disease-specific knowledge, it would be possible to enhance patient 
empowerment, resulting in an improved quality of life and prediction of the onset of 
an exacerbation. The Telekit system was installed by a technician in the patients’ 
home, and if the patients experienced various technical problems with the equipment 
or for other reasons desired to return the system, it was collected again by the 
technician who calibrated the equipment.  
The Telekit operated on an open source platform, OpenTele, which has been used to 
remotely monitor different patient groups in addition to COPD, including those with 
diabetes, hypertension, asthma, congestive heart failure, and pregnancy, in Denmark 
(122). The Telekit system was delivered to the patients in the TeleCare North trial in 
an iterative and dynamic process. Thus, in this PhD study, several usability tests 
were conducted to assess whether Telekit was a useful system (See Papers II-IV).  
Telekit consists of a Samsung Galaxy tablet (Samsung Galaxy TAB 2, 10.1, 
Samsung Electronics, Seoul, South Korea) (123), a fingertip pulse oximeter (Nonin, 
Onyx II% SpO2, A&D Medical, Tokyo, Japan) (124), a blood pressure monitor 
(Model UA-767, plus BT-C, Nonin Medical, Minnesota, USA) (125), a precision 
Randomization
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take part in the 
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to participate in the 
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health scale (UC-321PBT-C, A&D Medical, Tokyo, Japan) (125), a tablet pen, and a 
user guide [Paper I]. The Telekit system can be observed in Figure 3.  
 
Figure 3: The telehealthcare system, Telekit, consists of a tablet, a blood pressure monitor, a 
fingertip pulse oximeter, and a weight. 
The Telekit tablet has two apps. The first app, OpenTele, contains questionnaires 
that collect patients’ answers regarding their respiratory symptoms. The app also 
collects vital signs measured through Telekit’s devices via Bluetooth. Additionally, 
the patients have access to their measurements and access to a message function to 
initiate a conversation with the healthcare providers. This message function is for 
non-acute messages. The second app is a support app that contains a digital version 
of the instruction guide, several videos that illustrate how Telekit and the various 
devices can be used, and a training video targeted to patients with COPD (126).  
The COPD patients measured their respiratory symptoms and vital signs (heart rate, 
blood pressure, oxygen saturation, and weight) weekly through the Telekit system 
(see Figure 4). Patients’ data were monitored asynchronously and sent via wireless 
internet connection through the tablet to a platform that was viewed by district 
nurses in the municipalities. Patients had access to their data on the tablet or via the 
public health portal (www.sundhed.dk).  
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Figure 4: A patient with COPD is using the Telekit system to measure his vital signs. 
The GPs also had access to the health portal (www.sundhed.dk). The district nurses 
viewed the data from a web portal, OpenTele, on scheduled days in the week. These 
nurses manually interpreted the data based on color codes: green (normal values – 
no threshold values are exceeded); yellow (providers should be aware of the 
condition of patients – one or more threshold values are exceeded); and red (the 
patient’s condition is at risk, probably due to an exacerbation – one or more 
threshold values are exceeded and have not previously been recorded).The threshold 
values for the patients’ conditions were specified by the patients’ GPs. These color 
codes constituted a recommended order of reviewing the submitted data and were 
managed in accordance with the compiled instructions. The patients were contacted 
if their values fell outside these threshold values to establish further treatment. The 
intervention patients were able to keep the Telekit system and the control patients 
were offered the system after trial completion. The district nurses’ web portal and 
the telehealthcare system architecture are depicted in Figures 5 and 6, respectively. 
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Figure 5: The district nurses view the patient measurements from the web portal, OpenTele.  
 
Figure 6: The Telekit system framework. At home, patients were guided through their 
measurements using a tablet application. Devices used to measure the patients’ vital signs 
were connected to the tablet through Bluetooth. Patients could view their measurements via 
the tablet or the public health portal (www.sundhed.dk). The data were sent by patients to a 
central server, OpenTele, which stores data and ensures data exchange between relevant 
entities. District nurses could view the data from the web portal, OpenTele, and contacted the 
patients if deviations in their measurements occurred. 
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Instructional videos of the Telekit system and its connected devices can be viewed 
by visiting the following links (the videos are only recorded in Danish): 
Instructions on the use of the tablet: http://www.rn.dk/Sundhed/Til-sundhedsfaglige-
og-samarbejdspartnere/TeleCare-Nord/Instrukser-
KOL/Instruktionsvideoer/Instruktion-i-brug-af-tablet 
Instructions on the use of the blood pressure monitor: 
http://www.rn.dk/Sundhed/Til-sundhedsfaglige-og-samarbejdspartnere/TeleCare-
Nord/Instrukser-KOL/Instruktionsvideoer/Instruktion-i-brug-af-blodtryksmaaler 
Instructions on the use of the fingertip pulse oximeter: 
http://www.rn.dk/Sundhed/Til-sundhedsfaglige-og-samarbejdspartnere/TeleCare-
Nord/Instrukser-KOL/Instruktionsvideoer/Instruktion-i-brug-af-iltmaaler 
Instructions on the use of the weight: http://www.rn.dk/Sundhed/Til-
sundhedsfaglige-og-samarbejdspartnere/TeleCare-Nord/Instrukser-
KOL/Instruktionsvideoer/Instruktion-i-brug-af-vaegt 
 
2.4. SUMMARY OF THE BACKGROUND 
In this chapter, it was outlined that chronic obstructive pulmonary disease and other 
chronic diseases are responsible for a growing burden on the healthcare system. The 
burden of COPD has led to a need to develop other approaches to facilitate the 
treatment and care of these chronic patient groups. In recent years, technology has 
advanced exponentially, which has brought innovation into focus. Many health 
organizations are implementing health information technologies to reduce the 
incidence of hospitalizations and to prevent deterioration of chronic diseases. 
Telehealthcare could be a potential solution for managing COPD, but the evidence 
regarding its effects has yet to be determined. Another important factor to be 
addressed is the usability of telehealthcare and the user experiences with these 
telehealthcare technologies. Thus, large-scale trials are needed to provide evidence 
on the effectiveness of telehealthcare. A large-scale trial in Denmark, TeleCare 
North, was established to improve this lack of evidence by testing the effects of 
telehealthcare in patients suffering from COPD. 
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CHAPTER 3. AIMS AND OVERVIEWS 
OF THE PHD STUDY AND PAPERS 
In this chapter, the context, research questions, aims, and overview of the PhD study 
will first be described. This description is followed by a presentation of the specific 
purpose of each paper included in the PhD study. Finally, the chapter provides an 
overview of the thesis paper’s design/methods, subjects, and primary aims.    
3.1. CONTEXT OF THE PHD STUDY 
The PhD study was affiliated with the TeleCare North trial, the telehealthcare trial 
for COPD patients in the North Denmark Region. The population in the North 
Denmark Region is estimated to consist of approximately 45,000 COPD patients, 
and the number is growing. Of these, nearly 4,500 have severe or very severe COPD 
(127). The North Denmark Region is one of the five Danish regions and is divided 
into 11 municipalities with ten hospitals and approximately 350 GPs spread across 
200 medical practices (128).  
Four PhD students conducted an evaluation of the TeleCare North trial's intervention 
with the following scholarships:  
 A health-economics PhD scholarship from the Danish Centre for 
Healthcare Improvements, Aalborg University  
 
 A health-related/patient-oriented PhD scholarship from the Department of 
Health Science and Technology, Aalborg University 
 
 An organizational theory PhD scholarship from the Centre for 
Organization, Management and Administration, Aalborg University  
 
 A health literacy-based PhD scholarship from the Department of Health 
Science and Technology, Aalborg University.  
 
Figure 7 provides an overview of the four scholarships including their respective 
research areas.  
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Figure 7: The evaluation of the TeleCare North trial was carried out by four PhD students 
each in their specific research area.  
3.2. AIMS AND RESEARCH QUESTIONS OF THE PHD STUDY 
The overall aim of this PhD study was to evaluate a telehealthcare intervention for 
patients suffering from COPD. The focus areas of this PhD thesis were to provide a 
description of the TeleCare North trial’s intervention and to evaluate its outcomes 
regarding health-related quality of life (HRQoL), usability, and patient experiences.  
In particular, this thesis had a more specific focus on the following objectives with 
their corresponding research questions (Figure 8): 
The TeleCare North trial's four PhD scholarship 
Health- and 
patient-related 
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scholarship
PhD student,
Pernille Heyckendorff 
Lilholt
Health-
economics PhD 
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Figure 8: The PhD thesis aims and research questions.  
The research questions, depicted in Figure 8 will be considered and responded to 
through seven thesis papers (the answers to Q1-Q3 are presented in Chapter 6: 
General discussion and Chapter 7: Conclusion).   
3.3. OVERVIEW OF THE PHD STUDY 
The research in this PhD study was conducted in three phases. The first phase of the 
research process consisted of the development of TeleCare North trial´s protocol. 
The second phase comprised an evaluation of the telehealthcare system’s usability 
and the COPD patients’ user experiences. The final phase contained an evaluation of 
the TeleCare North trial’s primary outcome, HRQoL. Figure 9 illustrates the three 
phases with their related papers. 
Aim 1
• To develop a protocol that described the TeleCare North trial’s objectives, design, methodology, 
statistical considerations, ethical considerations, and organization
• Question 1 (Q1): How can the TeleCare North trial be described in detail by a protocol 
clarifying all procedures for assessing the effectiveness and cost-effectiveness of the trial? 
Aim 2
• To evaluate the Telekit system’s usability and the COPD patients’ satisfaction and user 
experiences with the system
• Question 2 (Q2): Is the Telekit system user-friendly and what are the COPD patients’ 
experiences with the system?
Aim 3
• To evaluate the primary outcome, HRQoL, of telehealthcare in addition to usual practice 
compared to usual practice
• Questions 3 (Q3): Are there any statistically significant changes in HRQoL between the two 
groups from baseline to 12-month follow-up?
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Figure 9: This PhD study was divided into three phases with associated papers. These papers 
provided answers to the three thesis research questions (Q1-Q3).   
3.4. SPECIFIC AIMS OF THE PAPERS 
Paper I: The aim was to evaluate the effectiveness and cost-effectiveness of a 
telehealthcare intervention for patients suffering from COPD compared to usual 
practice. 
Paper II: The aim was to evaluate the usability of the design of the telehealthcare 
system, named Telekit, early in the design process to assess potential problems and 
limitations that could hinder its user-friendliness and its successful implementation. 
Paper III: The aim was to evaluate the COPD patients’ satisfaction and user 
experiences with a revised version of the Telekit system. 
Paper IV: The aim was to evaluate Telekit’s usability using an iterative, mixed 
usability approach. 
Paper V: The aim was to explore the COPD patients’ user experiences with the 
Telekit in relation to increased control, freedom, security and greater awareness of 
their COPD symptoms. 
Paper VI: The aim was to examine the association between COPD patients’ use of 
Telekit and their functional health literacy and the association between their use of 
the Telekit system and their specific technological communication skills. 
Paper VII: The aim was to assess the effect of telehealthcare compared to usual 
practice based on an assessment of HRQoL in patients suffering from COPD. 
Phase III: Evaluation of the trial outcome, HRQoL 
Answers to Q3: Paper VII
Phase II: Evaluation of the Telekit system's usability and patient experiences
Answers to Q2: Paper II-VI
Phase I: Development of the trial's protocol
Answers to  Q1: Paper I
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3.5. OVERVIEW OF THE PAPERS 
The seven thesis papers’ design/methods, subjects and primary aims are illustrated 
in Table 4. 
Table 4: The seven papers included in the PhD study are listed below with information about 
the design/methods, subjects, and primary aim of each paper. 
Papers Design/methods Subjects Primary aim 
Paper I Protocol/cluster 
randomized trial 
COPD patients 
from the North 
Denmark Region 
To evaluate the effectiveness and cost-
effectiveness of telehealthcare compared to usual 
practice (cost-effectiveness is not addressed in 
this thesis) 
Paper II Heuristic 
evaluation 
5 usability experts To evaluate the usability of Telekit’s design 
early in the design process to assess potential 
problems that could affect the outcome of its 
implementation 
Paper III Think aloud test 6 COPD patients 
from the 
intervention group 
To evaluate the COPD patients’ satisfaction and 
user experiences with a revised version of the 
Telekit system 
Paper IV Iterative, mixed 
usability 
approach 
10 usability 
experts, 11 COPD 
patients from the 
intervention group 
To evaluate Telekit’s usability using an iterative, 
mixed usability approach 
Paper V Non-validated 
questionnaire 
60 COPD patients 
from the 
intervention group 
To explore the COPD patients’ user experiences 
with the Telekit system in relation to increased 
control, freedom, security and greater awareness 
of their COPD symptoms 
Paper VI TOFHLA 
test/Non-
validated 
questionnaire 
60 COPD patients 
from the 
intervention group 
To examine I) the association between COPD 
patients’ use of the telehealthcare system, 
Telekit, and their functional health literacy and 
II) the association between their use of the 
telehealthcare system, Telekit, and their specific 
technological communication skills 
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Paper VII Short Form (36) 
Health Survey 
1225 (n=578 
intervention; 
n=647 controls) 
COPD patients 
To assess the effect of telehealthcare compared 
to usual practice based on an assessment of 
HRQoL in COPD patients at the individual level 
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CHAPTER 4. SUMMARY OF PAPERS 
This chapter is divided into the three phases of the PhD study and their associated 
papers. The chapter includes a summary of each paper’s aim, methods, results, and 
discussion/conclusion. A more detailed description of the papers’ contents can be 
found in each paper separately. 
4.1. PHASE I: DEVELOPMENT OF THE TRIAL’S PROTOCOL 
4.1.1.  SUMMARY OF PAPER I 
Effectiveness and cost-effectiveness of telehealthcare for chronic obstructive 
pulmonary disease: study protocol for a cluster randomized controlled trial 
Aim: The objective of the TeleCare North trial was two-fold: 1) To evaluate the 
effectiveness in terms of HRQoL in patients with COPD and 2) to evaluate the cost-
effectiveness of implementing telehealthcare. The second part of the objective is not 
addressed in this thesis, as it is covered by another PhD student, Flemming Witt 
Udsen.   
Methods: TeleCare North was a cluster-randomized, pragmatic, controlled trial with 
12 month follow-up. We cluster-randomized 26 (with between 1 and 5 districts per 
municipality) matched municipality districts in the North Denmark Region. The 
municipalities were matched in terms of the municipality district’s size, population, 
unemployment rate, and the proportion of COPD > 40 years of age.  
The hospitals and the GPs in the North Denmark Region were responsible for 
including patients in the trial. GPs from the Region recruited patients from a list of 
potentially eligible patients in their practices. The COPD patients received detailed 
information about the study via brochures from the trial’s Administration Office and 
the GPs. Additionally, 30-minute appointments with GPs were established with each 
eligible patient, consisting of a conversation that was based on the forwarded 
brochure and patients’ baseline measurements. At this appointment, the COPD 
patients also signed written consent for participation. GPs transferred the threshold 
values of the baseline measurements for each patient to the municipalities 
electronically when the patients were included. Additionally, the GPs sent a return 
envelope with the baseline measurements and written consent to the trial’s 
Administration Office. Patients were eligible for inclusion if they were diagnosed 
with COPD, verified by spirometry (FEV1/FVC < 70%). Patients were excluded if 
they had problems understanding Danish, did not have telephone- or Global System 
for Mobile Communications (GSM) coverage, or had cognitive disabilities. The 
inclusion and exclusion criteria are listed in detail in Paper I.  
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The intervention included COPD patients receiving telehealthcare supplemented 
with existing usual practice. The compared alternative was patients receiving the 
existing usual practice and no form of telehealthcare. The existing usual practice 
involved treating, monitoring, and caring throughout the study period. The 
intervention patients were instructed on how to take the relevant measurements and 
how to use the telehealthcare system by appointments with their health care provider 
(district nurses). Patients were informed about taking daily vital sign measurements 
(blood pressure, heart rate, oxygen saturation, and weight) for the first 14 days after 
receiving the Telekit system and thereafter on a weekly basis after agreement with 
their GPs. District nurses from the municipalities reviewed patient measurements 
based on predefined threshold values on fixed weekdays. The district nurses 
followed up with a phone call when there were diverging measurements and planned 
patients’ next actions with the patients. The background section of this thesis and 
Paper I include more specific information regarding the trial’s design and 
intervention.   
The primary outcome was effectiveness defined by change in HRQoL at the 
individual level from baseline to 12-month follow-up. The primary outcome for 
cost-effectiveness was the incremental cost-effectiveness ratio (ICER) at the 
individual and cluster level measured from baseline to 12-month follow-up. The 
secondary outcomes for effectiveness were changes in mortality and vital signs from 
baseline to 12-month follow-up. An intention-to-treat principle was applied in the 
statistical analysis of the outcomes. See Paper VII for the evaluation of the primary 
outcome. The secondary outcomes of effectiveness and the outcomes concerning 
cost-effectiveness are not incorporated in this thesis or any of the thesis papers.  
Discussion: The TeleCare North trial aimed to improve the body of international 
evidence on the effectiveness and cost-effectiveness of telehealthcare in COPD 
patients by establishing a large-scale, cluster-randomized trial. The changes in 
outcomes were evaluated from baseline to 12-month follow-up. After the trial 
period, all recruited patients were offered telehealthcare. The trial outcomes were 
expected to be used as a Danish national standard for a technological platform and 
as a telehealthcare implementation model if the findings were favorable.  
The trial protocol was developed to increase the transparency of the TeleCare North 
trial. The protocol was registered at clinicaltrials.gov under trial no. NCT01984840 
before trial initiation.  
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4.1. PHASE II: EVALUATION OF THE TELEKIT SYSTEM’S 
USABILITY AND PATIENT EXPERIENCES 
4.1.1. SUMMARY OF PAPER II 
Heuristic evaluation of a telehealth system from the Danish TeleCare North trial 
Aim: In this paper, the usability of the telehealthcare system’s design was evaluated 
early in the design process to assess potential problems that could affect the outcome 
of its implementation. 
Methods: Five usability experts performed a heuristic evaluation of the Telekit 
system from the Danish TeleCare North trial. The experts evaluated Telekit’s 
interface for any problems using Jakob Nielsen’s ten heuristics and Rolf Molich’s 
severity classification. The experts evaluated the system based on designed 
scenarios, and whenever problems were identified, they were categorized into 
heuristics and given a score of severity. A debriefing session was carried out after all 
the experts had individually completed the heuristic evaluations. In this forum, all 
experts were gathered to discuss the positive and negative aspects of the system. The 
data from the heuristic evaluations were analyzed through simple bar charts to 
compare the experts’ identified problems.          
Results: The usability experts identified 152 problems through the heuristic 
evaluation, of which 86 (57%) were unique problems. Each expert documented 
between 22 and 40 problems with Telekit. The three most commonly used heuristics 
were “Match between system and the real world” (32%), “Consistency and 
standards” (13%), and “Aesthetic and minimalist design” (13%). The problems 
included in these heuristics were associated with the Telekit’s inability to speak the 
users’ language with words and phrases that were understandable and its ability to 
inform users about how measurements were to be obtained. The problems were most 
often given severity grades of “Improvement” (40%) and “Minor problem” (43%).  
The positive and negative aspects of the Telekit system were discussed during the 
debriefing. The three most positive aspects were the Telekit’s navigation system, its 
simple design, and its feedback. The three most serious aspects were the system’s 
lack of integrated help functions, lack of consistency in the design and content, and 
its failure to meet tablet standards. 
Discussion/Conclusion: The heuristic evaluation aimed to identify problems that 
could present an obstacle to users. By identifying potential problems, these could be 
addressed so that users could more easily access the system. The method was 
effective in finding problems with the interface, and although most problems were 
categorized as minor problems, it was recommended by all the usability experts to 
resolve them. The system was characterized as unfinished, given its use of small 
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buttons and the absence of touchscreen feedback. However, the system was 
considered simple in the design and usable for individuals who were unfamiliar with 
technology in general. Regardless, experts agreed on the need for interface 
improvements to make the Telekit more user-friendly. The heuristic evaluation was 
performed by experts and not the potential users, i.e., COPD patients. Therefore, the 
system should in the future undergo user tests after improvements have been made 
by Silverbullet, the company responsible for the system’s development (See Paper II 
for more detailed information about the heuristic evaluation of the Telekit system).  
CHAPTER 4. SUMMARY OF PAPERS 
 
53 
4.1.1. SUMMARY OF PAPER III 
User satisfaction and experience with a telehealth system for the Danish TeleCare 
North trial: A think-aloud study  
Aim: This paper aimed to evaluate the COPD patients’ satisfaction and user 
experiences with a redesigned version of the Telekit system. 
Methods: Six COPD patients (three women, three men) were randomly chosen to 
conduct a think-aloud test of the Telekit system. A heuristic evaluation had earlier 
been performed on the Telekit system to review the system for potential problems 
that could hinder its successful implementation (Paper II). The heuristic evaluation 
led to several changes to Telekit’s interface, and the revised system was then ready 
for user testing involving the patients’ satisfaction and user experiences with the 
system. The think-aloud test was performed in the patients’ homes, where the COPD 
patients completed representative tasks through the system. These tasks comprised 
the following 1) to log into the Telekit tablet; 2-3) to measure vital signs; 4) to 
identify graphical images of their measurements; 5) to use the message function; and 
6) to sign out of the Telekit tablet. Observations were made during the tests, and 
satisfaction was assessed using a developed questionnaire for this purpose.      
Results: The questionnaire – The patients assessed the Telekit system as user-
friendly, and there was consensus among patients that most people would be able to 
learn using the system. The time consumption varied among the patients, from using 
it on a weekly basis to even more frequently. Different technical assistance needs 
and the involvement of relatives in the utilization of the system were present. Some 
patients involved their healthcare provider or relatives, whereas others did not. In 
general, the patients were satisfied with the functionality of the Telekit system and 
were confident in using the system.   
Think aloud test and observations – All tasks were accomplished. Difficulty 
initiating a reaction on the touchscreen display was observed among some women 
due to having long fingernails or cold fingers. Some of the patients also had trouble 
identifying buttons, remembering passwords, and taking measurements in the 
appropriate order. The problems prevented patients from continuing through the 
system and from sending measurements. Some patients commented that the textual 
material in the Telekit system application was too extensive, and they wished for 
less text to facilitate readability.  
Discussion: Important knowledge was obtained during the test regarding the 
Telekit’s user-friendliness and the patients’ satisfaction. The patients were satisfied 
with the functionality of the Telekit system, and the feedback was mostly positive. 
However, different issues were identified concerning the textual material, interface 
design, and the need for a call center. The patients were all familiar with the Telekit 
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system before the tests took place, which could have meant they had acquired habits 
in using the system. Therefore, these patients could have been able to look past the 
problems that novices would have otherwise noticed. Valuable knowledge was 
obtained during the tests regarding the Telekit’s user-friendliness and the patients’ 
satisfaction. This knowledge is essential to improving current and future 
telehealthcare systems (See Paper III for more detailed information about the study).  
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4.1.1. SUMMERY OF PAPER IV 
An iterative, mixed usability approach applied to the Telekit system from the Danish 
TeleCare North trial 
Aim: The aim of this study was to evaluate Telekit’s usability using an iterative, 
mixed usability approach 
Methods: The study was carried out as an evaluation of the Telekit system and 
included a pre- and post-test. The former comprised a heuristic evaluation (HE1) 
and a think-aloud test (TA1), and the latter also comprised a heuristic evaluation 
(HE2) and a think-aloud test (TA2). In both heuristic evaluations, ten double 
usability experts (HE1: n= 5, HE2: n=5) participated, and 11 COPD patients from 
the TeleCare North trial took part in both think-aloud tests (TA1: n=6, TA2: n=5).  
In the heuristic evaluations, the usability experts found usability problems and 
classified them using Jakob Nielsen’s heuristics. The problems were also classified 
according to their severity based on Rolf Molich’s scale from zero to four. During 
the think-aloud tests, patients were asked to express their perceptions and thoughts 
about the Telekit while they performed representative tasks through the system.  
All four usability evaluations were carried out by a moderator and an observer and 
were recorded and audiotaped. The mixed usability approach produced both 
qualitative and quantitative data, which were combined and compared in the data 
analysis descriptively. The data were analyzed and compared as follows I) a pre- and 
post-test comparison of HE1 versus HE2, II) a pre- and post-test comparison of TA1 
versus TA2, and III) a post-test comparison of HE2 versus TA2.  
Results: Comparison of HE1 versus HE2 – In HE1, 152 problems were identified, 
of which 86 (57%) were unique. In HE2, 195 problems were found, of which 101 
(52%) were unique. See Paper IV for further details about the distribution of 
problems in the heuristics and the distribution of usability problems by the Rolf 
Molich’s severity rating scale. More specific information about the findings of these 
two evaluations can be found in Paper IV.  
Comparison of TA1 versus TA2 – A total of 12 themes were created based on the 
usability findings from the think-aloud tests: 1) Habits; 2) Lack of curiosity; 3) 
Information level; 4) The Telekit system – know how; 5) Comfort with the Telekit 
system; 6) Usability problems; 7) Learnability; 8) System feedback; 9) Content of 
the Telekit system; 10) Measurements; 11) The Telekit design, and 12) Relevance of 
the Telekit system. More themes with associated examples of usability problems 
were observed in TA2 compared with TA1. For further information about the 
content and presence of these twelve themes, see Paper IV.  
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Comparison of HE2 versus TA2 – Overall, the number of usability problems 
reported in HE2 was higher than the number of usability problems verbalized in 
TA2. In total, the experts identified the most (n=222), compared to the patients’ 
comments (n=76) and researcher observations (n=40). More specific knowledge 
regarding the comparisons of HE2 and TA2 can be obtained in Paper IV.   
Discussion/Conclusion: The Telekit system was evaluated through an iterative, 
mixed usability approach. The findings from the usability evaluations pointed to the 
importance of iteratively combining various methods. The findings from the study 
indicate that Telekit is suitable for supporting COPD patients in coping with their 
disease. The usability experts in HE1 generated substantial changes to the 
telehealthcare system, and new versions of the system were brought into operation. 
Subsequently, a think-aloud test, TA1, was carried out, in which patients verbalized 
their feelings and thoughts concerning the Telekit system. The post-test (HE2, TA2) 
was conducted approximately 12 months after.  
The comparison of HE1 and HE2 in the pre- and post-test showed that more 
problems were found in the post-test, which was relatively surprising because it was 
expected that this test would identify fewer problems. The identification of the 
number of the greater number of problems could be explained by Silverbullet’s (the 
company that developed Telekit) prioritization of the usability problems or by the 
different experts’ views on the system.  
The findings from the think-aloud tests, TA1 and TA2, indicated that most usability 
problems in the themes appeared in TA2. An explanation for this could be that 
Telekit’s usability decreased after TA1 instead of trending in the other direction 
towards an improvement of the system.  
A comparison of HE2 and TA2 was also performed and suggested that most 
usability problems were found through the heuristic evaluations versus the think-
aloud tests. The COPD patients and experts agreed on many usability aspects, but 
they also had different views, which was considered an advantage. The COPD 
patients also included the positive aspects of the system, whereas the experts only 
focused on identifying problems with the system’s functionality and design.  
In this study, a large body of material representing the experts’ and the patients’ 
perspectives on the usability aspects of Telekit was collected. Jakob Nielsen’s 
heuristics and Rolf Molich’s severity classification were used in all heuristic 
evaluations to increase comparability. The findings from the study supported the 
relevance of testing the Telekit system iteratively and using mixed methods to 
elucidate as many perspectives on the system as possible.  
The study was limited by the fact that not all experts had the opportunity to take part 
in both the pre- and post-test, which hindered the individual comparisons of the 
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results among experts. Another important limitation was the diverse versions of the 
Telekit system generated through the pre-test, which not could be avoided due to the 
corrections established in the system after the first heuristic evaluation, HE1. The 
findings of this study cannot be generalized to other telehealthcare systems that 
differ from the Telekit system.  
In conclusion, the Telekit system is fully operational, but in the future the system 
should still be evaluated to improve the usability of the system. Other evaluation 
methods, such as eye tracking, would be appropriate to implement with the system 
to supplement problems that were not assessed by other evaluation methods.  
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4.1.1. SUMMERY OF PAPER V 
Exploring user experience of a telehealth system for the Danish TeleCare North trial 
Aim: The purpose of this study was to explore the COPD patients’ user experiences 
with the Telekit System concerning increased control, freedom, security and greater 
awareness of their COPD symptoms.  
Methods: A non-standardized questionnaire consisting of 14 questions was 
developed to explore the patients’ user experiences with Telekit. The questionnaire 
was divided into three sections, with questions related to: I) the patients’ health 
status/characteristics, II) the patients’ use of specific technologies (computer, mobile 
phone, smartphone, and tablet), and III) the patients’ user experiences with the 
Telekit system.  
In total, 60 (27 women, 33 men) participants from the intervention group of the 
TeleCare North trial completed the questionnaire in the homes where a test 
responsible was present. The patients were all familiar with the Telekit system and 
had received instructions on the system by a healthcare provider two months before 
this study. The data from the patients’ responses were quantified and descriptively 
analyzed.    
Results: The majority of the patients (88%) considered the system simple to use. 
Most patients felt enhanced control (62%) and security (72%) by using the system. 
Half of the patients (50%) perceived greater awareness of their COPD symptoms. 
Finally, 27% of the patients answered positively to the question about experiencing 
enhanced freedom.  
Discussion/Conclusion: The study explored patients’ user experiences with Telekit 
to adjust the system to the COPD patients’ needs and abilities. Overall, the patients 
had positive experiences with the system and expressed increased control, freedom, 
security and a high awareness of their symptoms. These findings are also consistent 
with previous results of usability studies on the Telekit system. 
A weakness of this study was the small sample size, and it could have been more 
desirable to include the total number of patients from the intervention group in the 
survey. This study was also performed with patients who had possessed the Telekit 
for a relatively short amount of time, and as the patients’ experiences might change 
over time, it might have been worthwhile to ask the patients the same questions 
again after a longer period had elapsed.  
Regarding the study strengths, it should be mentioned that the patients were visited 
in their homes, which are assumed to provide a safe environment. The questionnaire 
was paper-based, which was believed to be beneficial because most of the COPD 
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patients were elderly individuals whose cognitive capabilities could be limited due 
to worsening disease.  
To conclude, the findings of the study provided essential knowledge about patients’ 
experiences, which also indirectly provided information about the implementation of 
the system and its success.  
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4.1.1. SUMMARY OF PAPER VI 
Specific technological communication skills and functional health literacy have no 
influence on self-reported benefits from enrollment in the TeleCare North trial 
Aim: This study’s purpose was to investigate: I) the association between COPD 
patients’ use of the telehealthcare system, Telekit, and their functional health literacy 
and II) the association between their use of the telehealthcare system, Telekit, and 
their specific technological communication skills.   
Methods: A consecutive sample of the intervention group (n=60) in the TeleCare 
North trial participated in the study. The intervention patients had used the 
telehealthcare system for two months when this study was carried out. 
Face-to-face interviews were conducted with each individual to obtain the following 
demographic data: gender, age, and educational level. All patients performed a 
Danish TOFHLA test, which measured their functional health literacy, and 
completed a non-standardized questionnaire about their health status, their use of the 
Telekit system, and their specific technological communication skills. The 
questionnaire included the following: seven questions about patients’ health status, 
disease severity, and activity level; four questions about Telekit’s ability to enhance 
patients’ sense of freedom, security, control, and awareness of their COPD 
symptoms; one question about Telekit’s ease of use; and two questions concerning 
the patients’ use of communication technologies (e.g., tablet, mobile phone, etc.) 
and their specific skills (e.g., searching for information, paying bills, sending 
SMS/MMS, etc.) with these technologies. The questions were used for descriptive 
statistics, except for the last question, which was used to investigate the association 
between the patients’ skills and their benefits from using the telehealth system. The 
questionnaire is presented in Paper VI as supplementary material.  
Descriptive statistics and binary logistic regressions were suitable to investigate how 
functional health literacy and specific technological communication skills affected 
the use of the telehealthcare system by providing users an enhanced sense of 
freedom, security, control, and a greater awareness of COPD symptoms. The logistic 
regression models were investigated by calculating the odds ratios, and their 
respective 95% confidence intervals.  
Results: Participants’ characteristics – In total, 60 (28 women, 33 men) COPD 
patients with a mean age of 70 (SD: 8.37) years participated in the study. The 
majority of patients were skilled (45%) or were elementary school educated (35%). 
The mean functional health literacy score was 71.42; 14 (23%) of the patients were 
classified as having inadequate functional health literacy, 12 (20%) as having 
marginal, and 34 (57%) as having adequate literacy. See Paper VI for more detailed 
information about the descriptive characteristics of the patients.  
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Association between the use of the telehealthcare system and functional health 
literacy – The functional health literacy score had no statistically significant effect 
on the utilization of the telehealthcare system regarding its contribution to the users’ 
experience of increased control, freedom, security, and greater awareness of 
symptoms. 
Association between the use of the telehealthcare system and specific technological 
communication skills – The number of specific communication skills had no 
statistically significant effect on the utilization of the telehealthcare system 
regarding its contribution to the users’ experience of increased control, freedom, 
security, and greater awareness of symptoms. 
Discussion/Conclusion: This study investigated: I) the association between the use 
of the telehealthcare system and functional health literacy and II) the association 
between the use of the telehealthcare system and the number of specific 
communication skills. The majority of the participants felt enhanced security, 
control, freedom and greater awareness of their COPD symptoms, but no association 
between the benefit obtained from using the system, health literacy, and specific 
technological communication skills were identified.  
This study took place in the patients’ environment, and the investigator was present 
during the test to clarify questions and ensure a high response rate, which was 
considered an advantage of this study. A paper-based format of the questionnaire 
might be more favorable instead of the online format due to the assumption that 
chronic patients may have cognitive difficulties. The patients’ own home was 
chosen to establish a pleasant atmosphere that created the least possible stress during 
the test situation – this should have led to an increased quality of the test and 
questionnaire responses. The generalizability of the study was considered high due 
to the diverse sample of patients. Nonetheless, these findings cannot be generalized 
to other telehealthcare studies using telehealthcare systems other than Telekit.  
The study could be limited by the self-reported responses, which could give rise to 
social desirability bias and satisfying strategies because of the investigator’s 
presence. Therefore, it is possible that the patients responded more positively than 
actually intended or chose a more neutral response option to complete the test and 
questionnaire quickly. The questionnaire was based on relevant literature to ensure 
content validity. Psychometric tests would have been preferable to perform on the 
non-standardized questionnaire to assure the questionnaire’s validity and reliability.  
In conclusion, the study demonstrated that functional health literacy and specific 
communication skills did not have any effects on the experience of using the 
telehealthcare system. Based on the findings, it is assumed that specific 
communication skills and functional health literacy are not preconditions for using 
the Telekit system (See Paper VI for more specific information about the study).  
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4.1. PHASE III: EVALUATION OF THE TRIAL OUTCOME, HRQOL  
4.1.1. SUMMARY OF PAPER VII 
Telehealthcare for patients suffering from COPD: Effects on health-related quality 
of life – results from the Danish “TeleCare North” cluster-randomised trial 
Aim: The study aimed to evaluate the effect of telehealthcare in addition to usual 
practice compared with usual practice alone based on an assessment of HRQoL in 
COPD patients at the individual level.   
Methods: This study was nested within the TeleCare North trial and was established 
in consensus with the trial protocol (Paper I). More detailed information about the 
study design can be obtained through the trial protocol (Paper I). The COPD patients 
(n=1225) in the intervention and control group received the Short-Form (36) Health 
Survey at baseline and after 12 months of follow-up. The survey measured the 
patients’ HRQoL based on summary scores of physical (PCS) and mental 
component scores (MCS). The scores ranged from 0 (maximum disability) to 100 
(no disability). The patients completed the questionnaire at home and were able to 
contact the study investigators for help in clarifying the questions. The importance 
of responding in the best possible manner and the importance of completing all the 
questions was made clear to the patients.     
The study’s primary outcomes were related to the patients’ mean differences in 
HRQoL over time from baseline to the 12-month follow-up at the individual level. 
The primary outcome was the adjusted mean differences in the groups’ summary 
component scores (PCS, MCS) from baseline to 12-month follow-up. The secondary 
outcomes were based on a subgroup analysis of the mean differences in summary 
scores (PCS, MCS) at the clustered level. The summary scores were calculated by 
using QualityMetric Incorporated (http://www.sf-36.org/). The effectiveness 
analysis followed the intention-to-treat principle. The data were analyzed using 
linear mixed models for continuous outcomes to evaluate the mean differences in 
scores between groups over the 12-month period.    
Results: In total, 1225 (578 intervention, 647 controls) patients were included at 
baseline (see the CONSORT participant flow diagram in supplementary material, 
Paper VII). Socio-demographic characteristics and clinical characteristics were 
assessed at baseline and indicated no significant differences between groups, except 
for FVC% (p<0.05). The control groups’ mean FVC% (74.34%) was slightly higher 
than of the intervention group.  
Unadjusted and adjusted primary outcomes - The unadjusted significant differences 
in HRQoL scores between groups showed a decline in scores from baseline to 
follow-up at 12 months. The mean difference in the intervention group’s PCS score 
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was -2.62 (95% CI, -1.9238464 to -3.317276), and the control group’s was -2.83 
(95% CI, -2.16342096; -3.494888704). The mean difference in MCS score for the 
intervention group was -4.69 (95% CI, -3.76360248; -5.61360952) and was -5.31 
(95% CI, -4.44201504; -6.17870496) for the controls. For both groups, the mean 
differences in scores combined were MCS: 0.3771 (95% CI, 1.7506; 2.5049) and 
PCS: 0.1813 (95% CI, 1.3848; 1.7474). The confidence intervals indicated a 
statistically nonsignificant difference in unadjusted mean HRQoL scores between 
the intervention and control groups. 
The groups’ adjusted mean differences in HRQoL from baseline to 12-month 
follow-up were PCS: 0.1399 (95% CI, -1.3689; 1.6496) and MCS: 0.3603 (95% CI, 
-1.6788; 2.3994). No statistically significant differences were found concerning the 
adjusted outcomes between groups.  
To summarize, the mean differences in the summary scores through the trial period 
were larger for the control group, which might suggest a more rapid deterioration 
over the 12 months in the control group compared with the intervention group. The 
difference was largest in the MCS, which points to a slower decline in mental health 
for the telehealthcare group. However, no statistically differences were found 
between groups.  
The secondary outcomes - A subgroup analysis defined as posteriori was also 
conducted in this study and indicated no statistically significant effect of the 
intervention in any of the defined subgroups.   
Discussion/Conclusion: This study was conducted to improve the evidence on the 
HRQoL of patients suffering from COPD. HRQoL was assessed from baseline to 
follow-up at 12 months in both groups, and these values were compared against each 
other. The findings indicated no significant differences in HRQoL over time 
between groups and subgroups. However, there was a trend towards positive effects 
in HRQoL among certain subgroups.      
The study was based on our knowledge of the largest studies that on an international 
level, tried to create better evidence for telehealthcare in one chronic disease, 
namely COPD. The SF-36v2 (the Short-Form (36) Health Survey, version 2) was 
used to evaluate HRQoL from baseline to follow-up. The SF-36v2 is a generic and 
validated questionnaire that is used for both healthy and sick individuals; however, it 
might not be sensitive enough to detect a change in HRQoL among COPD patients. 
A more disease-specific questionnaire such as the St. George Respiratory 
Questionnaire would have been desirable as a supplement  to assess changes in 
quality of life over time.      
A comparison of the baseline values of FVC% between groups indicated that the 
intervention group was sicker than the controls. The difference in FVC% might 
explain why there was no significant difference in HRQoL between groups over 
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time. The Hawthorne effect could also have affected the outcome and led to the lack 
of difference between groups. Some of the COPD patients could have enhanced 
their engagement and changed their behavior simply as a result of their enrollment 
in the study and the increased awareness of being observed by researchers and 
healthcare providers.  
In the future, the focus should be on finding answers for this study’s lack of proven 
effectiveness. The reason for the lack of effects might be due to the fact that some 
patients benefit more from telehealthcare than others or that some municipalities in 
the North Denmark Region have been better about implementing telehealthcare than 
others. The specific subgroups should also be considered in assessing which patients 
will most benefit from telehealthcare. Identifiable effects may exist among 
subgroups of the intervention group. Thus, a mixture of both qualitative and 
quantitative research is needed to gain a clearer understanding of the relationship 
between quality of life and telehealthcare. More studies on a larger scale are not 
advisable until this relationship has been further investigated. Policy makers and 
healthcare providers should be directed towards other indicators for implementing 
telehealthcare in practice such as reducing costs, reducing mortality or improving 
clinical outcomes.   
In conclusion, this study has obtained more evidence for the effects of HRQoL in 
telehealthcare. Based on the study results, the telehealthcare intervention 
supplemented with patient education did not improve the COPD patients’ HRQoL 
over 12 months. However, telehealthcare with existing care did not lead to poorer 
HRQoL compared with usual practice. 
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CHAPTER 6. GENERAL DISCUSSION 
In this chapter, an interpretation of the main findings derived from the three phases 
of the PhD study will be presented by providing answers to Q1-Q3. The 
interpretation of the main findings is followed by methodological considerations in 
which the strengths and limitations of the TeleCare North trial’s intervention and 
outcomes regarding usability, user experiences, and HRQoL will be discussed. 
Finally, implications for practice will be discussed together with suggestions for 
future research.  
This PhD study concerned COPD patients, a heavy burdened group of patients who 
incur high costs for both the patients and society (21,129). The increasing costs of 
care and the declining health resources create a need to change the management of 
COPD to one in which patients play a more active role in the treatment and care of 
their disease (57,58). Telehealthcare services have the potential to support user 
involvement and to promote higher professional, organizational and patient-
perceived quality of overall healthcare, and they are being used increasingly to 
create more efficiency in healthcare (62,72,73). Implementing telehealthcare 
systems is often a costly expense that affects patients, clinicians, and other 
healthcare stakeholders, demonstrating the importance of choosing an adequate 
research design to evaluate interventions. Nevertheless, reviews have discussed the 
difficulty of making comparisons between telehealthcare and usual practice due to 
the lack of comparable research studies and evaluations (80–82). Consequently, 
there is still not enough evidence regarding the effects of telehealthcare (12,77,78), 
which has created a demand for large-scale studies, such as the TeleCare North trial, 
to evaluate such interventions.  
The objective of this PhD study was to contribute to improving the body of evidence 
on telehealthcare by evaluating the TeleCare North trial’s intervention. The PhD 
research had a more specific focus on: I) developing a trial protocol for the Danish, 
large-scale trial, TeleCare North; II) evaluating the trial’s telehealthcare system 
regarding its usability and patient experiences; and III) evaluating the trial’s 
outcome regarding health-related quality of life (HRQoL).    
6.1. MAIN FINDINGS 
The main findings of the PhD study will be described by providing answers to the 
following specific questions:  
Q1: How can the TeleCare North trial be described in detail by a 
protocol clarifying all procedures for assessing the effectiveness and 
cost-effectiveness of the trial? 
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Q2: Is the Telekit system user-friendly and what are the COPD patients’ 
experiences with the system? 
Q3: Are there any statistically significant changes in HRQoL between 
the two groups from baseline to 12-month follow-up? 
6.1.1. PHASE I: DEVELOPMENT OF THE TRIAL'S PROTOCOL 
How can the TeleCare North trial be described in detail by a protocol clarifying 
all procedures for assessing the effectiveness and cost-effectiveness of the trial? 
The TeleCare North trial was among the biggest large-scale studies at the 
international level and was the first of its kind in Denmark to evaluate the 
effectiveness and cost-effectiveness of telehealthcare. The trial used a pragmatic 
cluster-randomized design to provide sufficient evidence on telehealthcare compared 
to usual practice in patients suffering from COPD. The effectiveness and cost-
effectiveness were assessed by evaluating changes in health-related quality of life 
and costs from baseline to 12-month follow-up. The cost-effectiveness outcomes of 
the trial were not integrated into this PhD study, as the health economics domain 
pertained to another PhD student, Flemming Witt Udsen. The TeleCare North trial 
was carried out according to a research plan, more precisely a study protocol that 
contained all the steps (background, objectives of the study, study design, duration, 
participants, recruitment, randomization, intervention, outcomes, sample size, 
statistical, and ethical considerations) of the study. 
Paper I comprised the fixed study protocol for the TeleCare North trial. The 
protocol was developed to clarify the trial procedure and to avoid poor scientific 
work with invalid data and incorrect statistical analyses. The TeleCare North trial 
was described according to the CONSORT Extension for Cluster Trials (130) to 
ensure transparency in the reporting process. The protocol was registered on 
www.clinicaltrials.gov before trial initiation and subsequently published in TRIALS. 
COPD patients in the North Denmark Region were cluster-randomized to an 
intervention group or a control group. The control group received the existing usual 
practice, and the intervention group received telehealthcare along with the existing 
usual practice. The intervention group was provided the telehealthcare system, 
Telekit, and was trained in using the system by a healthcare provider at two planned 
appointments. Intervention group patients were instructed to measure their vital 
signs and to respond to questions on disease-related symptoms at home on fixed 
days after agreement with their respective GPs was reached.  
The monitored data were reviewed by healthcare providers in the municipalities on 
scheduled days. The patients’ data were transferred into risk profiles (red, yellow, 
green) based on threshold values to guide the healthcare providers in their 
identification and assessment of high-risk patients. The healthcare providers 
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contacted the patients if their data deviated from the normal threshold values with a 
risk of disease deterioration. The Telekit system was not an emergency service, and 
patients were therefore informed to consult their GPs or doctors in emergency 
services in case of exacerbations. After the TeleCare North trial’s completion, the 
control group was also offered telehealthcare due to ethical considerations (see 
Paper I for further details about the TeleCare North trial’s design and intervention).  
6.1.2. PHASE II: EVALUATION OF THE TELEKIT SYSTEM’S USABILITY 
AND PATIENT EXPERIENCES 
Is the Telekit system user-friendly and what are the COPD patients’ experiences 
with the system? 
The telehealthcare system, Telekit, used in the TeleCare North trial was developed 
with the purpose of improving patients’ empowerment by involving the patients in 
caring for their illness and by increasing their coping skills through self-monitoring. 
Usability is a fundamental element to consider when offering telehealthcare to 
patients suffering from COPD (105,112,113). Living at home with a chronic disease 
can be very anxiety provoking and isolating (131,132), and COPD patients are 
typically elderly with limited cognitive and physical capabilities, highlighting the 
importance of striving to make telehealthcare as user-friendly as possible by 
modifying telehealthcare systems to the patients’ needs (110,111). The current 
evidence points in general to positive user experiences with telehealthcare, but more 
knowledge within specific population groups is necessary, demonstrating the 
importance of testing the usability of telehealthcare systems (133). 
Papers II-VI present the evaluation of Telekit’s usability and the patients’ 
experiences and satisfaction with the use of the system. In Paper II, a heuristic 
evaluation with five usability experts was performed to identify potential usability 
problems that could affect the success of the implementation of the Telekit system. 
The experts identified 152 usability problems, of which 86 were unique. Some of 
these problems were subsequently revised according to priorities to improve 
Telekit’s design. The experts characterized the system as unfinished, but in general, 
there was consensus about the system’s simple design and functionality, and the 
experts agreed that the system was suitable for COPD patients who were unfamiliar 
with technology. Subsequently, Telekit underwent improvements and was revised to 
address the usability problems in order of priority. However, the heuristic evaluation 
was not able to assess how the end users would interact with the system’s interface, 
which called for more usability evaluations involving user testing. 
In paper III, a think-aloud test was therefore performed in which six patients 
interacted with the Telekit system on the basis of constructed user scenarios. The 
patients were observed and asked to express their thoughts and feelings about the 
system as they performed the representative tasks. The think-aloud test resulted in 
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an evaluation of the Telekit’s usability and the patients’ satisfaction with the system. 
The findings confirmed that Telekit was user-friendly, as evidenced by the patients’ 
satisfaction with the functionalities integrated in the system and by observing their 
interactions with the system.    
An iterative, mixed usability approach was also conducted because the previous 
heuristic evaluations and think-aloud tests revealed that Telekit needed further 
design improvements. In Paper IV, the iterative approach encompassed a pre- and 
post-test, including the aforementioned heuristic evaluation and think-aloud test 
along with a new version of each test. These usability evaluations were compared 
and generated both qualitative and quantitative findings on the prevalence, severity, 
and content of the usability issues in Telekit. Most problems were identified in the 
post-test, which was surprising because it was assumed that fewer usability issues 
would occur after conducting more evaluations. The findings of Paper IV illustrated 
the importance of working iteratively and using mixed usability methods in the 
evaluation of telehealthcare systems.  
In addition to the various usability tests, a survey, described in Paper V, was 
conducted in the patients’ home to investigate more specifically the patients’ self-
reported benefits of using Telekit. These findings indicated that 53 (88%) perceived 
the system as easy to use. The patients experienced benefits regarding enhanced 
control (61.7%) and security (71.7%) after using the system. Additionally, 50% felt 
greater awareness of their COPD symptoms in responding to disease deterioration 
and some patients (26.7%) also perceived increased freedom. In Paper VI, 
associations were made between: I) the patient benefits of using Telekit and the 
patients’ functional health literacy; and II) the patient benefits of using Telekit and 
their specific technological communication skills. These findings demonstrated that 
the patients’ self-reported benefits attained by using the telehealthcare system were 
not associated with the patients’ functional health literacy level and communication 
skills. Patients’ communication skills and health literacy levels were revealed to not 
be prerequisites for the use of the Telekit system.    
Overall, the series of usability evaluations from phase II showed that telehealthcare 
was an adequate service to help patients in their self-care. The Telekit system proved 
to be stable in operation and patients gained positive experiences from using the 
system. The Telekit system received criticism from several usability experts, who 
designated the system’s app to be old-fashioned in design compared to newer apps. 
However, during the user tests, the patients expressed that they appreciated that the 
system was straightforward and easy to use. One noteworthy lesson derived from the 
series of usability studies was to keep the Telekit system as simple as possible (see 
Paper II-IV for further details about the series of usability studies). 
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6.1.3. PHASE III: EVALUATION OF THE TRIAL OUTCOME, HRQOL  
Are there any statistically significant changes in HRQoL between the two groups 
from baseline to 12-month follow-up? 
In Paper VII, an intention-to-treat analysis was carried out to evaluate the effects of 
HRQoL from baseline to 12-month follow-up. The primary outcome, HRQoL, of 
1,225 COPD patients was evaluated, of whom 578 were in position of the Telekit 
system. The Short-Form (36) Health Survey, version 2, was distributed to patients at 
study enrollment and after 12 months to compare the two groups’ HRQoL 
outcomes. The questionnaire contained 36 questions that measured patients’ HRQoL 
based on a mental- (MCS) and a physical (PCS) summary score.  
At baseline, the patients’ mean age in the intervention group was 69.55 (9.36) years, 
and in the control group, it was 70.33 (9.11) years. The patients represented different 
degrees of disease severity, which were distributed as follows: GOLD I (6%), 
GOLD II (38%), GOLD III (39%) and GOLD VI (17%). No differences in baseline 
variables were found between the groups, except for a statistically significant 
difference in FVC% (p < 0.05).  
The differences between the intervention and the control groups’ HRQoL were 
compared, which indicated that telehealthcare compared to usual practice did not 
lead to poorer quality of life. A slower deterioration was observed among the 
intervention patients receiving telehealthcare. However, no statistically significant 
differences in HRQoL were identified between the intervention- and control group 
or between subgroups of the population.  
In comparison with other studies, Cartwright et al. (134) studied a similar 
intervention in the Whole System Demonstrator Project (WSD) and found no 
improvement in HRQoL as a result of telehealth. Other comparable studies, e.g., the 
Virtual Hospital trial (135) and the Telescot study (136), likewise found no 
significant differences in HRQoL among patients with COPD. Thus, the findings 
from the TeleCare North trial correspond well with the mentioned studies’ results. 
The rationale behind the TeleCare North trial’s intervention, specifically enhancing 
patient empowerment with patient education and strengthening the organizational 
focus on detecting disease deterioration, was found to not be able to improve the 
patients’ HRQoL.   
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6.2. METHODOLOGICAL CONSIDERATIONS 
6.2.1. THE TELECARE NORTH TRIAL  
Strengths and limitations of the trial  
Trial design: At the international level, the TeleCare North trial was among the 
largest large-scale studies. At the national level, the trial was the first of its kind in 
the Danish context. The TeleCare North trial was constructed as a pragmatic, cluster 
randomized controlled design. The trial's purpose was to evaluate the effectiveness 
and cost-effectiveness of telehealthcare in addition to usual practice compared with 
only usual practice in patients suffering from COPD. This type of research design is 
relevant for studying a large number of people (137) and was selected to increase the 
feasibility of implementing the study in a real-life operational context. Another 
reason for selecting the study design was to avoid contamination and recruitment 
bias (138) (see Paper I for further details).  
However, there are some limitations to applying this design in the evaluation of 
telehealthcare. Some research cannot be adequately addressed by a randomized trial 
such as complex interventions. Telehealthcare interventions are more complex than 
other types of interventions because they are dependent on human behavior, 
participant engagement, and other contributing factors (139,140). The effectiveness 
of telehealthcare is not only related to the effects of the service itself but also to the 
effects of a combination of intervention and context. Utilizing a mixed method 
approach to evaluate effectiveness might have been a better choice in the evaluation 
of the TeleCare North trial’s intervention (141). A mixture of RCTs and other 
research designs and methods are appropriate to assess fully complex interventions 
(142). Using both qualitative and quantitative evaluation methods are needed as a 
supplement to the gold standard to explain why and how an intervention actually 
works (143). Implementing telehealthcare in routine care is considered to be a 
complex intervention that involves a number of components: people, processes, 
infrastructure, and technologies, and the outcomes of these interventions therefore 
depend on these components. Using a mixed methods approach, it might be possible 
to achieve an understanding of the complex link between these components in the 
context of a given intervention.     
The inclusion and exclusion criteria: The inclusion and exclusion criteria were 
similar to those used in other telehealthcare studies and those listed in the GOLD 
guidelines (21) to increase comparability. The broad range of COPD patients with 
different stages of COPD severity may have improved the trial’s external validity. 
The external validity could lead to an understanding of the mechanisms that produce 
the effects (e.g., the interaction between intervention and context, including patients, 
relatives, and care personnel).  
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Patient recruitment: The recruitment of patients was delegated to GPs in the North 
Denmark Region from May 2013 to November 2013. To support the identification 
of patients for inclusion, patient lists with potential COPD patients were generated 
for each clinic/hospital. A conflict between the Danish Medical Association 
(www.læger.dk) and Danish Regions (www.regioner.dk) limited some GPs’ 
motivation to include a sufficient number of patients, which also led to the hospitals’ 
involvement in the enrolment process. However, the general practices referred 
approximately 900 patients and the hospitals approximately 300 patients during the 
inclusion period. According to the research protocol, the same inclusion criteria 
were used at the hospitals and in the practices.  
Cluster randomization: The randomization was performed by an external person 
who was not affiliated with the trial. In contrast to WSD (134,144–147), the 
randomization of patients was not at the general practice level but rather at the 
municipality district level. In that way, we prevented healthcare providers in the 
same municipality district from providing care for patients in both groups. The 
randomization divided the patients into two comparable groups, in which no 
differences in case distribution between the two groups were found except for in 
FVC%. The intervention group’s FVC% was slightly higher than that of the control 
group. Therefore, it can be argued that the patients in the telehealthcare group were 
sicker at baseline than the control group.   
Study duration: The study duration was limited to 12 months due to ethical 
considerations and other reasons such as related costs. Patients in the control group 
should have received the same offer of telehealthcare after 12 months. A longer 
follow-up period would be desirable to examine the long-term effects. However, the 
timeframe of 12 months was considered appropriate to detect these long-term 
effects.  
The effect size: The effect size was estimated by findings from a previous 
Norwegian study; (148) combined with an expected dropout rate of 10%, the 
estimated required total sample was 800 patients. The recruited sample of 1,225 
patients was considered large enough to detect a minimal clinically important 
difference in HRQoL. 
Instruction of patients on telehealthcare: The instructions provided to the patients 
were carried out in the municipalities in different ways because the training in the 
Telekit was completed by either the health care centers or the district nurses. Several 
municipalities had both individual and group training, and some of the 
municipalities might have been better at educating and organizing the telehealthcare 
services than others. However, all municipalities’ instructions were based on the 
same training guidelines produced by the trial’s Administration Office.      
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Data collection: The data analysis followed the intention-to-treat principle, in which 
all patients were analyzed according to the group to which they were randomly 
assigned to provide the strongest possible basis for inference about the treatment 
effects and to eliminate all risks of bias (149).  
After the inclusion of patients in the trial, GPs electronically transferred threshold 
values based on baseline measurements for each patient to the municipalities and to 
the trial’s Administration Office. Several of the baseline clinical measurements were 
not noted, which caused some missing values in the data analysis.  
Loss to follow-up was also a cause of missing values in the data analysis. The most 
frequent reasons for dropout were deaths, relatives’ deaths or disease deterioration, 
which affected the patients’ abilities or resources to participate in the TeleCare 
North trial. Some patients withdrew due to a lack of cognitive function or emigration 
from the North Denmark Region. A small number of patients chose to leave the trial 
due to technical issues with the Telekit or due to disappointment in not belonging to 
the intervention group.   
In Paper VII, the COPD patients were stratified into the four GOLD groups (I-IV) 
(21) based on their FEV1 value; this indicated that the majority of patients were in 
the moderate (II) to severe (III) stages of COPD. It would have been more desirable 
to use the updated GOLD classification (A-D) (21), which ranks patients based on 
other factors and symptoms in addition to their degree of airflow obstructions. In 
that way, it would have been possible to delineate more appropriate subgroups.     
Effectiveness Outcomes: The primary outcome of effectiveness was change in 
HRQoL at the individual level from baseline to 12-month follow-up. The secondary 
outcomes were changes in mortality and physiological parameters from baseline to 
12-month follow-up. The secondary outcomes still need to be evaluated, as some 
effects of the telehealthcare intervention might be observed among these outcomes. 
Other valid and reliable measures of outcomes of interest could have been used in 
the evaluation such as anxiety, depression, etc. However, HRQoL was selected as 
the primary outcome to enhance the comparability to other telehealthcare studies.   
6.2.2.  THE TELEKIT SYSTEM’S USABILITY AND PATIENT 
EXPERIENCES 
Strength and limitations of the usability studies 
The series of usability studies (Paper II-VI) performed on the Telekit system had 
some advantages and disadvantages.  
First of all, the usability studies supported the process of the Telekit system CE 
being marked and approved as a medical device class II, which can be used for 
clinical decision support.  
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Second, all usability tests (Paper II-IV) were designed in collaboration with at least a 
second author of the paper to ensure credibility. The usability tests were recorded, 
and a plan for each test was developed before conducting the usability tests to help 
manage and organize the usability evaluations.  
Third, the choice to use mixed usability evaluation methods iteratively elicited 
several perspectives on the use of the Telekit system. The experts and COPD 
patients focused on different aspects of usability. The experts paid attention to the 
system design and functionalities, whereas the patients focused on the meaning 
behind the use of the system. The overlooked usability issues that were not 
identified in one evaluation method could be discovered by repeating the test or by 
another evaluation method. The choice of using mixed evaluation methods is also 
supported by usability expert, Jakob Nielsen (150).  
Lastly, the think aloud tests (Paper III, IV) were completed by real end users, which 
strengthens the representativeness. The usability tests (Paper III-VI) took place in 
the patients’ home in real settings, which was assumed to provide a safer and more 
pleasant environment, which could expedite the patients’ thoughts about the Telekit.  
A limitation was that the COPD patients had received instructions on the system in 
advance, which could have led to the formation of habits in using the system. It 
would have been interesting to test inexperienced patients; however, the Telekit was 
not designed for use without instructions. 
In Papers V and VI, a non-standardized self-reported questionnaire was used to 
explore the patients’ user experiences with the Telekit. Psychometric tests were not 
performed on this questionnaire, but these tests could have enhanced the 
questionnaire’s construction, reliability, and validity.   
6.2.3. OUTCOME OF THE TELECARE NORTH TRIAL 
Strength and limitations of the outcome evaluation 
A generic validated questionnaire, the SF-36, version 2, was utilized in the 
evaluation of HRQoL, the outcome of the intervention. The SF-36 is validated and 
considered to be an appropriate measure to compare changes in HRQoL between 
groups (151). Nevertheless, it would have been optimal to use a disease-specific 
questionnaire as a supplement. The SF-36 may not be sensitive enough to detect 
changes in HRQoL among COPD patients, suggesting a disease-specific 
questionnaire would be suitable as an alternative (152). Reviews by Chen (152) and 
Engström et al. (153) have also confirmed the importance of using a combination of 
generic and disease-specific questionnaires. However, this combination was not 
chosen because it could encumber patients with yet another questionnaire and 
because of the risk of receiving fewer responses.   
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The lack of a significant difference could be due to the duration of the trial period. 
The 12-month follow-up was perhaps too short a period to identify a change in 
HRQoL. However, the sample size calculation was designed to detect differences in 
HRQoL between the groups, making this possibility more unlikely. The non-
significant results could also be explained by the fact that telehealthcare was a new 
technology that required patients and healthcare providers to learn how to use the 
technology. COPD patients should learn to manage their disease condition in 
relation to its symptoms and the overall burden that comes with living with the 
disease. Another explanation that might have affected the patients’ quality of life 
was that the Telekit system simply did not address all of the patients’ needs.   
The underlying mechanisms, including improved patient empowerment and 
increased organizational focus, failed to demonstrate effectiveness. These 
mechanisms were intended to provide effects, making it unclear what types of other 
factors have a decisive role in demonstrating detectable effects. A combination of 
the SF-36 questionnaire and qualitative interviews would have been preferable to 
obtain a more nuanced picture of the complex connection between quality of life and 
telehealthcare in patients with COPD.      
The choice of primary outcome, HRQoL, used to evaluate the effectiveness can also 
be discussed. HRQoL was an appropriate measure because it is frequently used to 
assess the effects of such interventions and is a valid measure to assess QoL in the 
population (151). Other alternative outcome variables of clinical characteristics 
could have been selected, but due to time constraints, they were not included in this 
PhD study.    
6.3. IMPLICATIONS FOR PRACTICE 
The outcomes (Paper VII) of this trial suggest that telehealthcare in addition to usual 
practice did not improve the HRQoL of patients with COPD. However, some 
subgroups might experience potential benefits in HRQoL from using telehealthcare. 
The lack of a significant difference in effect between the intervention and control 
groups indicates that additional telehealthcare will not benefit all patients, nor the 
average COPD patient. Telehealthcare may provide patient satisfaction and 
enhanced security, freedom, control, and awareness of symptoms but not increased 
health (Papers II-VI).  
Policymakers, stakeholders, and healthcare providers should consider the purposes 
and effects that define the underlying reasons for implementing telehealthcare, e.g., 
costs, clinical outcomes, or mortality. Additionally, stakeholders should identify 
strategies to direct telehealthcare to the COPD patients who are most likely to 
benefit from such interventions. This knowledge is essential in designing 
telehealthcare systems that are better tailored to the individual and the context of 
use. 
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6.4. FUTURE DIRECTIONS AND PERSPECTIVES 
The TeleCare North trial’s intervention has been integrated as a general offer for 
patients with COPD in the North Denmark Region. Policymakers and stakeholders 
in the Region have also decided to deploy a large-scale study in patients with heart 
failure. This new large-scale study will be implemented over a two-year period from 
December 2015 to November 2017.  
Local Government Denmark has also decided to spread the use of telehealthcare to 
COPD patients nationwide. The national implementation will be based on the 
TeleCare North trial’s gained experiences. In the national implementation, decision-
makers considered the experiences and findings from the TeleCare North trial in the 
way that health gains existed for the subgroup with severe COPD, GOLD stage III 
(21). Therefore, telehealthcare will be deployed nationally for this group despite the 
fact that we have not actually demonstrated this assumption, and this should, 
therefore, be examined more specifically and preferably before national 
implementation. 
There are also other unknown areas that should be investigated further, and future 
research still needs to address the following: 
 The usability evaluations performed through this PhD study included only 
COPD patients as users. Future usability evaluations of the system should 
also consider the perspectives of other users, such as the healthcare 
providers, to adapt the system to their needs of monitoring patients’ data. 
 
 Usability is one factor that can promote satisfaction with telehealthcare 
systems such as Telekit. Other factors could also have been addressed to 
guarantee satisfaction such as organizational factors and patient factors. 
These factors should be considered in future studies. 
 
 Future research should investigate the patients’ user experiences in the 
TeleCare North trial after a longer follow-up period to explore whether 
their experiences change.  
 
 Consideration should be given to integrating other functionalities in the 
Telekit system, such as motivating training functions.  
 
 Building on the experiences learned from the TeleCare North trial, it could 
be useful to consider assessing whether the effects concerning HRQoL are 
distinct between patients suffering from COPD and those with heart 
disease. 
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 The underlying mechanisms and preconditions required to enhance 
patients’ HRQoL need to be explored through qualitative research.   
 
 A mixed research approach exploring patients’ quality of life by combining 
the SF-36 with individual interviews might increase the understanding of 
this study’s outcome.  
 
 More research is needed to examine which patients benefit the most from 
telehealthcare because some patients may experience a greater benefit from 
telehealthcare than others. A priori-defined subgroup analyses for COPD 
using clinical outcomes should, therefore, be carried out. 
 
 The possibility of standardizing the selection of patients based on a 
stratification decision support system that selects patients on the basis of 
telehealthcare outcomes combined with other socio-demographic and 
health characteristics should be investigated.  
 
 Evaluations of the outlined secondary clinical outcomes of the TeleCare 
North trial have to be performed. 
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CHAPTER 7. CONCLUSION 
In conclusion, this PhD thesis attempted to describe the TeleCare North trial’s 
research design and to evaluate the Telekit system regarding HRQoL, usability, and 
patient experiences. In this chapter, the answers to the three research questions (Q1, 
Q2, Q3) of the PhD study are provided: 
Q1: How can the TeleCare North trial be described in detail by a 
protocol clarifying all procedures for assessing the effectiveness and 
cost-effectiveness of the trial?  
Patients suffering from COPD in the North Denmark Region were asked to 
participate in the TeleCare North trial and randomized to telehealthcare in 
combination with usual practice or usual practice, alone. In the protocol, the research 
design of the TeleCare North trial and all the procedures used to assess effectiveness 
and cost-effectiveness were presented to ensure transparency (Paper I).   
Q2: Is the Telekit system user-friendly and what are the COPD patients’ 
experiences with the system? 
Telekit has proven to be capable of monitoring COPD at a distance. The usability 
evaluations of the system indicated that the Telekit system needed design and 
functionality improvements, but in general, the patients expressed positive user 
experiences and satisfaction with the system. There will be continuing need for 
evaluation of the telehealthcare system through an iterative process to adapt the 
system to the COPD patients’ needs (Paper II-VI).  
Q3: Is there any statistically significant changes in HRQoL between the 
two groups from baseline to 12-month follow-up 
The work presented in this thesis found no statistically significant differences in 
HRQoL between groups from baseline to the 12-month follow-up. Thus, based on 
these findings, the TeleCare North trial’s telehealthcare intervention cannot be 
recommended as a potential service to enhance COPD patients’ HRQoL. However, 
the telehealthcare intervention might have other clinical, economic or organizational 
effects that simply have not been addressed in this PhD study. These results have 
provided insights into the effects of telehealthcare on HRQoL. Although no 
significant differences between treatment groups and subgroups were found, a trend 
towards a slower disease deterioration in HRQoL was observed within certain 
subgroups of the intervention group when compared with those receiving usual care. 
This slower deterioration may indicate that at the least, telehealthcare does not lead 
to poorer HRQoL over time (Paper VII). 
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The healthcare system is facing challenges regarding the treatment of chron-
ic obstructive pulmonary disease (COPD), which necessitating alternative ways 
to treat these patients. Telehealthcare could be this alternative. A range of stud-
ies have been conducted to evaluate the effectiveness of telehealthcare, but 
they generally conclude that there is a need for more large-scale studies to ob-
tain sufficient evidence. In this context, a Danish large-scale trial (TeleCare 
North) was launched in the North Denmark Region in 2012 to enable the man-
agement of COPD from patients’ home environments through telehealthcare. 
The overall aim of this dissertation was to evaluate the TeleCare North trial’s inter-
vention. The PhD thesis focused more specifically on I) developing a trial protocol 
for the Danish, cluster-randomized, large-scale trial, TeleCare North; II) evaluating 
the trial’s telehealthcare system, Telekit, in terms of its usability and patient experi-
ences; and III) evaluating the trial’s outcomes regarding health-related quality of life 
(HRQoL). These focus areas were addressed in seven papers.
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